Activity-dependent neuronal signalling and autism spectrum disorder
Open accessAbstract
Neuronal activity induces the post-translational modification of synaptic molecules, promotes localized protein synthesis within dendrites and activates gene transcription, thereby regulating synaptic function and allowing neuronal circuits to respond dynamically to experience. Evidence indicates that many of the genes that are mutated in autism spectrum disorder are crucial components of the activity-dependent signalling networks that regulate synapse development and plasticity. Dysregulation of activity-dependent signalling pathways in neurons may, therefore, have a key role in the aetiology of autism spectrum disorder.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 225 cited sources checked · 0 supported · 0 flagged
- Interpretationnone given
Many genes mutated in ASD are essential components of activity-dependent signalling networks that control synapse development and plasticity.
“Evidence indicates that many of the genes that are mutated in autism spectrum disorders are crucial components of the activity-dependent signalling networks that regulate synapse development and plasticity.”
Quote in the paperNot a substantial claim - Premisecitation
Some ASD-associated mutations are limited to a specific gene and cause syndromic neurodevelopmental disorders with highly penetrant autism features, including Fragile X syndrome, tuberous sclerosis complex, Angelman syndrome, Timothy syndrome and Rett syndrome.
“In some cases, the mutations are limited to a specific gene and result in syndromic neurodevelopmental disorders with highly penetrant features of autism. These include Fragile X syndrome, tuberous sclerosis complex, Angelman syndrome, Timothy syndrome and Rett syndrome2.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Zoghbi, H. Y. & Bear, M. F. Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb. Perspect. Biol. 4, a009886 (2012). source
Not checked in the free run.
- Interpretationreasoning
Impairment of multiple, different molecular pathways that are not mutually exclusive probably contributes to the development of various subsets or aspects of ASD.
“Indeed, impairment of multiple, different molecular pathways that are not mutually exclusive, probably contributes to the development of various subsets, or aspects, of ASD.”
Quote in the paperSubstantial claim - Premisecitation
Rare genetic variations play a significant part in the aetiology of ASD.
“Rare genetic variations play a significant part in the aetiology of ASD.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [5] State, M. W. & Levitt, P. The conundrums of understanding genetic risks for autism spectrum disorders. Nature Neurosci. 14, 1499–1506 (2011). source
Not checked in the free run.
- cites [32] Sanders, S. J. et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70, 863–885 (2011). source
Not checked in the free run.
- Interpretationreasoning
Many mutations associated with ASD lead to alterations in excitatory or inhibitory neurotransmission that disrupt activity-dependent signalling and activity-dependent synapse development, maturation and refinement.
“Many of the mutations associated with ASD lead to alterations in excitatory or inhibitory neurotransmission that disrupt activity-dependent signalling and disrupt activity-dependent synapse development, maturation and refinement.”
Quote in the paperSubstantial claim
- Premisecitation
Neuronal activity triggers local synaptic changes that alter the composition, shape and strength of synapses.
“Neuronal activity triggers local changes at the synapse, altering the composition, shape and strength of the synapse.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] Cohen, S. & Greenberg, M. E. Communication between the synapse and the nucleus in neuronal development, plasticity, and disease. Annu. Rev. Cell Dev. Biol. 24, 183–209 (2008). source
Not checked in the free run.
- Premisecitation
Mutations in voltage-gated L-type calcium channels that flux calcium to initiate activity-dependent gene transcription are associated with Timothy syndrome, which has a significant association with ASD phenotypes.
“For example, mutations in the voltage-gated L-type calcium channels that flux calcium to initiate activity-dependent gene transcription are associated with Timothy syndrome, which is characterized by impairments in cardiac and immune function and has a significant association with ASD phenotypes31.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] Splawski, I. et al. CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19–31 (2004). source
Not checked in the free run.
- Premisenone given
The signalling network controlling synapse development and function contains many proteins whose expression or function is regulated by neuronal activity.
“An interesting feature of this signalling network is that it is composed of many proteins for which expression or function is regulated by neuronal activity, suggesting that one cause of ASD may be the dysregulation of neuronal activity-dependent synapse development and function.”
Quote in the paperSubstantial claim - Interpretationreasoning
Disruption of activity-dependent molecular programs that control synaptic function significantly contributes to the molecular basis of ASD.
“Taken together, these findings are beginning to provide compelling evidence that disruption of activity-dependent molecular programs that control synaptic function significantly contributes to the molecular basis of ASD.”
Quote in the paperSubstantial claim - Premisecitation
ASD is largely a genetic disorder.
“Research has shown unequivocally that ASD is largely a genetic disorder4.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Abrahams, B. S. & Geschwind, D. H. Advances in autism genetics: on the threshold of a new neurobiology. Nature Rev. Genet. 9, 341–355 (2008). source
Not checked in the free run.
- Premisecitation
Many proteins in the activity-dependent signalling network that controls gene transcription are implicated in disorders of cognition and behaviour, including ASD.
“Many of the proteins that form the activity-dependent signalling network that controls gene transcription are implicated in disorders of cognition and behaviour, including ASD (Fig. 3).”
Quote in the paperSubstantial claim - Premisecitation
ASD is often caused by newly arising CNVs or rare germline mutations, particularly in sperm of older fathers.
“ASD is often due to newly arising gene copy number variants (CNVs) — such as a deletion or duplication of a region of a chromosome — or a rare mutation that arises in the germ cell, particularly in sperm of older fathers5–10.”
Quote in the paperNot a substantial claim0 of 6 sources checked- cites [5] State, M. W. & Levitt, P. The conundrums of understanding genetic risks for autism spectrum disorders. Nature Neurosci. 14, 1499–1506 (2011). source
Not checked in the free run.
- cites [6] Malhotra, D. & Sebat, J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 148, 1223–1241 (2012). source
Not checked in the free run.
- cites [7] Sanders, S. J. et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237–241 (2012). source
Not checked in the free run.
- cites [8] Neale, B. M. et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242–245 (2012). source
Not checked in the free run.
- cites [9] O'Roak, B. J. et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nature Genet. 43, 585–589 (2011). source
Not checked in the free run.
- cites [10] Kong, A. et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 488, 471–475 (2012). References 7–10 demonstrate the ability of new sequencing technologies to significantly advance our understanding of the genetic basis of ASD. source
Not checked in the free run.
- Interpretationreasoning
Dysregulation of activity-dependent signalling pathways in neurons may play a key role in the aetiology of ASD.
“Dysregulation of activity-dependent signalling pathways in neurons may therefore,have a key role in the aetiology of autism spectrum disorders.”
Quote in the paperSubstantial claim - Premisecitation
Sensory, cognitive and emotional experiences shape synapse and neural-circuit development in the human brain.
“A cardinal feature of human brain development is that sensory, cognitive and emotional experiences shape synapse and neural-circuit development.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [14] Wiesel, T. N. Postnatal development of the visual cortex and the influence of environment. Nature 299, 583–591 (1982). source
Not checked in the free run.
- cites [15] Cohen, S. & Greenberg, M. E. Communication between the synapse and the nucleus in neuronal development, plasticity, and disease. Annu. Rev. Cell Dev. Biol. 24, 183–209 (2008). source
Not checked in the free run.
- Premisenone given
Neuronal activity regulates the function, localization and expression of many proteins associated with ASD.
“In addition, neuronal activity clearly regulates the function, localization and expression of many of the proteins that are associated with ASD.”
Quote in the paperSubstantial claim - Premisenone given
A convergent molecular pathway dysregulated in ASD is the signalling network controlling synapse development and function.
“Recent studies suggest that a convergent molecular pathway dysregulated in ASD is the signalling network that controls synapse development and function.”
Quote in the paperNot a substantial claim - Interpretationreasoning
One cause of ASD may be dysregulation of neuronal activity-dependent synapse development and function.
“An interesting feature of this signalling network is that it is composed of many proteins for which expression or function is regulated by neuronal activity, suggesting that one cause of ASD may be the dysregulation of neuronal activity-dependent synapse development and function.”
Quote in the paperSubstantial claim - Interpretationreasoning
The current weight of evidence does not conclusively demonstrate that dysregulation of activity-dependent neuronal signalling is the singular cause of ASD.
“The current weight of evidence does not conclusively demonstrate that dysregulation of activity-dependent neuronal signalling is the singular cause of ASD.”
Quote in the paperSubstantial claim - Premisecitation
Several de novo CNVs associated with ASD have been detected multiple times, including CNVs at 16p11.2, 15q11-13, 22q11.2, deletions at NRXN1, and duplications at 7q11.23.
“Several de novo CNVs that are associated with ASD have been detected multiple times, including CNVs at 16p11.2, 15q11–13, 22q11.2, deletions at NRXN1, and duplications at 7q11.235,32.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [5] State, M. W. & Levitt, P. The conundrums of understanding genetic risks for autism spectrum disorders. Nature Neurosci. 14, 1499–1506 (2011). source
Not checked in the free run.
- cites [32] Sanders, S. J. et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70, 863–885 (2011). source
Not checked in the free run.
- Interpretationreasoning
The finding that many genes involved in activity-dependent gene transcription are associated with human cognitive disorders, including ASD, supports the hypothesis that dysregulation of activity-dependent signalling networks may contribute significantly to synaptic dysfunction in ASD.
“The finding that many of the genes that are involved in activity-dependent gene transcription are associated with human disorders of cognitive function, including ASD, provides support for the hypothesis that dysregulation of activity-dependent signalling networks in general may contribute significantly to the synaptic dysfunction that occurs in ASD.”
Quote in the paperSubstantial claim - Premisecitation
De novo mutations arising in the germline are a significant cause of ASD.
“Recent evidence suggests that de novo mutations that arise in the germline are a significant cause of ASD, although it is important to keep in mind that the genetic aetiology of about 70% of the forms of ASD is unknown and it remains perplexing why ASD is at least four times more prevalent in males than in females.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [9] O'Roak, B. J. et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nature Genet. 43, 585–589 (2011). source
Not checked in the free run.
- cites [10] Kong, A. et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 488, 471–475 (2012). References 7–10 demonstrate the ability of new sequencing technologies to significantly advance our understanding of the genetic basis of ASD. source
Not checked in the free run.
- Interpretationreasoning
Emerging evidence indicates that genes and proteins associated with ASD are both regulated by and control activity-dependent pathways that modulate synaptic function.
“However, as we review here, there is emerging evidence that genes and proteins associated with ASD are both regulated by and control activity-dependent pathways that modulate synaptic function.”
Quote in the paperSubstantial claim - Premisecitation
Neurexins bind other postsynaptic transmembrane proteins, including LRR transmembrane proteins, in addition to neuroligins, increasing the number of potential trans-synaptic connections.
“In addition to binding neuroligins, neurexins bind other postsynaptic transmembrane proteins, including leucine-rich repeat (LRR) transmembrane proteins, adding to the number of different potential trans-synaptic connections16.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] Missler, M., Sudhof, T. C. & Biederer, T. Synaptic cell adhesion. Cold Spring Harb. Perspect. Biol. 4, a005694 (2012). source
Not checked in the free run.
- Interpretationreasoning
Genetic loci associated with ASD may disrupt gene function not only through mutations in coding sequences but also through disruption of regulatory regions controlling these genes.
“A crucial consideration is that genetic loci associated with ASD may not only be found to disrupt gene function through mutations within gene-coding sequences, but may also be found to disrupt the function of the regulatory regions that control these genes.”
Quote in the paperSubstantial claim - Premisecitation
Exome sequencing of parent-offspring trios has identified de novo exonic mutations in SCN2A, KATNAL2, CHD8, FOXP1, NTNG1, GRIN2B, and LAMC3, extending the number of genes for which mutation may contribute to ASD.
“In addition, very recent exome sequencing of parent-offspring trios has identified de novo exonic mutations in SCN2A, KATNAL2, CHD8, FOXP1, NTNG1, GRIN2B, LAMC3(refs 7–9), extending further the number of genes for which mutation may contribute to ASD.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [7] Sanders, S. J. et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237–241 (2012). source
Not checked in the free run.
- cites [8] Neale, B. M. et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242–245 (2012). source
Not checked in the free run.
- cites [9] O'Roak, B. J. et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nature Genet. 43, 585–589 (2011). source
Not checked in the free run.
- Interpretationreasoning
This suggests that activity-dependent functions of Nlgn-1 may be disrupted in ASD.
“This suggests that activity-dependent functions of Nlgn-1 may be disrupted in ASD.”
Quote in the paperSubstantial claim - Premisecitation
Overexpression of Nlgn1 containing an ASD-associated missense mutation leads to a decrease in the number and strength of excitatory synapses, in contrast to wild-type Nlgn1.
“In contrast with overexpression of wild-type Nlgn1, overexpression of Nlgn1 containing an ASD-associated missense mutation leads to a decrease in the number and strength of excitatory synapses41.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [41] Chubykin, A. A. et al. Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 54, 919–931 (2007). This study reports the crucial role for neuroligins in activity-dependent synapse maturation and how this pathway is dysregulated by ASD-associated mutations in neuroligin. source
Not checked in the free run.
- Interpretationreasoning
The repeated detection of these CNVs in individuals with ASD strongly suggests that mutations in these genomic regions contribute to ASD.
“The fact that these CNVs have been detected in multiple individuals with ASD strongly suggests that mutations in these regions of the genome are contributing to ASD.”
Quote in the paperSubstantial claim - Premisecitation
A recent study identified thousands of neuronal activity-regulated enhancers of transcription that could potentially be sites of human variation leading to ASD.
“Of note, therefore, is a recent study that identified thousands of neuronal activity-regulated enhancers of transcription that could potentially be sites of human variation that lead to ASD36.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [36] Kim, T. K. et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 465, 182–187 (2010). source
Not checked in the free run.
- Premisecitation
There is increasing evidence that neurexins, neuroligins and LRR transmembrane proteins are involved in activity-dependent programs that modulate synapse function.
“There is increasing evidence for the involvement of neurexins, neuroligins and LRR transmembrane proteins in activity-dependent programs that modulate synapse function.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] Missler, M., Sudhof, T. C. & Biederer, T. Synaptic cell adhesion. Cold Spring Harb. Perspect. Biol. 4, a005694 (2012). source
Not checked in the free run.
- Premisecitation
Rare mutations in multiple members of the neuroligin and neurexin families of synaptic adhesion molecules have repeatedly been found to be associated with ASD.
“Rare mutations in multiple members of the neuroligin and neurexin families of synaptic adhesion molecules have repeatedly been found to be associated with ASD5.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] State, M. W. & Levitt, P. The conundrums of understanding genetic risks for autism spectrum disorders. Nature Neurosci. 14, 1499–1506 (2011). source
Not checked in the free run.
- Premisecitation
Mutations in multiple synaptic cell adhesion molecules and PSD components are associated with ASD.
“Mutations in multiple synaptic cell adhesion molecules and components of the PSD are associated with ASD.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] State, M. W. & Levitt, P. The conundrums of understanding genetic risks for autism spectrum disorders. Nature Neurosci. 14, 1499–1506 (2011). source
Not checked in the free run.
- Premisecitation
Neuroligins regulate the activity-dependent maturation and modulation of synapses.
“Notably, neuroligins have been found to regulate the activity-dependent maturation and modulation of synapses.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [41] Chubykin, A. A. et al. Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 54, 919–931 (2007). This study reports the crucial role for neuroligins in activity-dependent synapse maturation and how this pathway is dysregulated by ASD-associated mutations in neuroligin. source
Not checked in the free run.
- cites [42] Kim, J. et al. Neuroligin-1 is required for normal expression of LTP and associative fear memory in the amygdala of adult animals. Proc. Natl Acad. Sci. USA 105, 9087–9092 (2008). source
Not checked in the free run.
- cites [43] Choi, Y. B. et al. Neurexin-neuroligin transsynaptic interaction mediates learning-related synaptic remodeling and long-term facilitation in Aplysia. Neuron 70, 468–481 (2011). Using the Aplysia model, this study demonstrates that the neurexin–neuroligin interaction regulates activity-dependent synaptic development and plasticity, a process that is dysregulated by an ASD-associated mutation in neuroligin. source
Not checked in the free run.
- Premisecitation
Several genetic loci associated with ASD (UBE3B, CLTCL1, NCKAP5L, ZNF18) include genes whose expression is induced by neuronal activity.
“Several genetic loci (UBE3B, CLTCL1, NCKAP5L and ZNF18) that are associated with ASD include genes for which expression is induced by neuronal activity34,35.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [34] Morrow, E. M. et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 321, 218–223 (2008). This paper provides evidence for the hypothesis that genetic mutations associated with ASD may disrupt activity-dependent gene expression programs. source
Not checked in the free run.
- cites [35] Chahrour, M. H. et al. Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism. PLoS Genet. 8, e1002635 (2012). source
Not checked in the free run.
- Interpretationreasoning
Studying genes mutated in these syndromes has the potential to provide insight into the molecular and cellular basis of ASD.
“Thus, as described later, studying the genes that are mutated in these widely studied syndromes has the potential to provide insight into the molecular and cellular basis of ASD.”
Quote in the paperNot a substantial claim - Premisecitation
Several widely studied syndromic disorders, such as Fragile X, with penetrant autism spectrum features have provided useful insight into the pathophysiology of ASD.
“In addition to these rare mutations, several widely studied syndromic disorders, such as Fragile X, with penetrant autism spectrum features have provided useful insight into the pathophysiology of ASD.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Bhakar, A. L., Dolen, G. & Bear, M. F. The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci. 35, 417–443 (2012). source
Not checked in the free run.
- Premisecitation
Overexpression of neuroligin with an ASD-associated mutation blocked intermediate and long-term facilitation at the sensory-to-motor neuron synapse, relative to wild-type neuroligin.
“Relative to wild-type neuroligin, overexpression of neuroligin with an ASD-associated mutation blocked intermediate and long-term facilitation at the sensory-to-motor neuron synapse43.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [43] Choi, Y. B. et al. Neurexin-neuroligin transsynaptic interaction mediates learning-related synaptic remodeling and long-term facilitation in Aplysia. Neuron 70, 468–481 (2011). Using the Aplysia model, this study demonstrates that the neurexin–neuroligin interaction regulates activity-dependent synaptic development and plasticity, a process that is dysregulated by an ASD-associated mutation in neuroligin. source
Not checked in the free run.
- Premisecitation
Knock-in mice with the neuroligin-3 ASD missense mutation Nlgn3(R451C) display impaired social interactions, recapitulating a key ASD feature.
“For example, knock-in mice that harbour the neuroligin-3 ASD missense mutation Nlgn3(R451C) display impaired social interactions, recapitulating a key feature of ASD38.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [38] Tabuchi, K. et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71–76 (2007). source
Not checked in the free run.
- Premisenone given
Mutations in NRXN1 are associated with ASD in humans.
“In addition to the neuroligins, mutations in NRXN1 are also associated with ASD in humans.”
Quote in the paperNot a substantial claim - Premisecitation
Fragile X syndrome results from a CGG trinucleotide expansion in FMR1, which encodes FMRP.
“Fragile X syndrome results from a trinucleotide expansion (CGG) in FMR1, which encodes fragile X mental retardation protein (FMRP).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Bhakar, A. L., Dolen, G. & Bear, M. F. The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci. 35, 417–443 (2012). source
Not checked in the free run.
- Premisecitation
Knockdown of transcription factors mediating activity-regulated gene transcription, including MEF2 and NPAS4, decreased expression of multiple ASD-linked genes (c3orf58, SLC9A9, PCDH10).
“In addition, knockdown of several transcription factors that mediate activity-regulated gene transcription, including MEF2 and NPAS4, led to decreased expression of multiple genes that are linked to ASD (c3orf58, SLC9A9, and PCDH10)34.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [34] Morrow, E. M. et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 321, 218–223 (2008). This paper provides evidence for the hypothesis that genetic mutations associated with ASD may disrupt activity-dependent gene expression programs. source
Not checked in the free run.
- Premisecitation
Shank2 and Shank3 knockout mice show changes in excitatory neurotransmission that correlate with ASD behavioural phenotypes.
“These Shank2 and Shank3 knockout mice display alterations in excitatory neurotransmission that correlate with ASD behavioural phenotypes.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [47] Peca, J. et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472, 437–442 (2011). source
Not checked in the free run.
- cites [48] Schmeisser, M. J. et al. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 486, 256–260 (2012). source
Not checked in the free run.
- cites [49] Won, H. et al. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486, 261–265 (2012). References 47–49 demonstrate the role of Shanks in regulating excitatory neurotransmission. source
Not checked in the free run.
- Premisecitation
Shank3 knockout mice have deficits in striatal glutamatergic synapse structure and function, including reduced cortico-striatal synaptic transmission.
“The Shank3 knockout mice have deficits in striatal glutamatergic synapse structure and function, including reduced cortico-striatal synaptic transmission47”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [47] Peca, J. et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472, 437–442 (2011). source
Not checked in the free run.
- Premisecitation
Excessive protein synthesis in Fmr1 knockout mice is reversed by mGluR5 antagonists.
“Remarkably, the excessive protein synthesis observed in Fmr1 knockout mice is reversed by antagonists of mGluR5.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] Huber, K. M., Gallagher, S. M., Warren, S. T. & Bear, M. F. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl Acad. Sci. USA 99, 7746–7750 (2002). source
Not checked in the free run.
- Interpretationcitation
Activity-dependent degradation of synaptic proteins, including Shank family proteins, regulates reorganization of synapses and memories.
“These findings suggest that the activity-dependent degradation of synaptic proteins, including those of the Shank family, regulates the reorganization of synapses and memories.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [50] Ehlers, M. D. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nature Neurosci. 6, 231–242 (2003). source
Not checked in the free run.
- cites [51] Bingol, B. & Sheng, M. Deconstruction for reconstruction: the role of proteolysis in neural plasticity and disease. Neuron 69, 22–32 (2011). source
Not checked in the free run.
- cites [52] Hung, A. Y., Sung, C. C., Brito, I. L. & Sheng, M. Degradation of postsynaptic scaffold GKAP and regulation of dendritic spine morphology by the TRIM3 ubiquitin ligase in rat hippocampal neurons. PLoS ONE 5, e9842 (2010). source
Not checked in the free run.
- Premisecitation
Neuronal activity changes the molecular composition of the postsynaptic compartment by inducing ubiquitination and proteasome-mediated degradation of a subset of PSD proteins, including Shank family proteins, leading to altered synaptic signalling.
“Neuronal activity has been shown to affect the molecular composition of the post-synaptic compartment by inducing the ubiquitination and proteasome-mediated degradation of a subset of PSD proteins, including those of the Shank family, thus leading to changes in synaptic signalling50,51.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [50] Ehlers, M. D. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nature Neurosci. 6, 231–242 (2003). source
Not checked in the free run.
- cites [51] Bingol, B. & Sheng, M. Deconstruction for reconstruction: the role of proteolysis in neural plasticity and disease. Neuron 69, 22–32 (2011). source
Not checked in the free run.
- Premisecitation
FMR1, TSC1, TSC2, and PTEN have key roles in protein synthesis-dependent synaptic plasticity.
“Several genes that are mutated in ASD — FMR1, TSC1, TSC2 and PTEN — have key roles in protein synthesis-dependent plasticity of synapses (Fig. 2)13,23.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [13] Kelleher, R. J. III & Bear, M. F. The autistic neuron: troubled translation? Cell 135, 401–406 (2008). source
Not checked in the free run.
- cites [23] Bhakar, A. L., Dolen, G. & Bear, M. F. The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci. 35, 417–443 (2012). source
Not checked in the free run.
- Premisecitation
FMRP negatively regulates translation of specific mRNAs at the synapse.
“This protein negatively regulates the translation of specific mRNAs at the synapse23,54.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [23] Bhakar, A. L., Dolen, G. & Bear, M. F. The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci. 35, 417–443 (2012). source
Not checked in the free run.
- cites [54] Zalfa, F. et al. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 112, 317–327 (2003). source
Not checked in the free run.
- Premisecitation
Genetic and pharmacological inhibition of mGluR5 reverses synaptic and behavioural impairments in Fmr1 knockout mice.
“In addition, both genetic and pharmacological inhibition of mGluR5 reverses synaptic and behavioural impairments in these mice.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] Huber, K. M., Gallagher, S. M., Warren, S. T. & Bear, M. F. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl Acad. Sci. USA 99, 7746–7750 (2002). source
Not checked in the free run.
- Premisecitation
Rare mutations linked to ASD occur in SHANK2, SHANK3, and SHANK1.
“Rare mutations associated with ASD have been found in SHANK2 and SHANK3 (ref. 5), and recently in SHANK1 (ref. 46).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [5] State, M. W. & Levitt, P. The conundrums of understanding genetic risks for autism spectrum disorders. Nature Neurosci. 14, 1499–1506 (2011). source
Not checked in the free run.
- cites [46] Sato, D. et al. SHANK1 deletions in males with autism spectrum disorder. Am. J. Hum. Genet. 90, 879–887 (2012). source
Not checked in the free run.
- Interpretationcitation
Impaired NMDA receptor function may be a key mechanism by which mutations in Shank family genes lead to ASD.
“suggesting that impairment of NMDA receptor functioning may be a key mechanism through which mutations in genes that encode the Shank family of proteins lead to ASD49.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [49] Won, H. et al. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486, 261–265 (2012). References 47–49 demonstrate the role of Shanks in regulating excitatory neurotransmission. source
Not checked in the free run.
- Premisereasoning
These findings are the basis of human clinical trials testing mGluR5 antagonists for Fragile X syndrome.
“These findings are the basis of human clinical trials that aim to test the efficacy of mGluR5 antagonists for the treating Fragile X syndrome23,56–58.”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [23] Bhakar, A. L., Dolen, G. & Bear, M. F. The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci. 35, 417–443 (2012). source
Not checked in the free run.
- cites [56] Bear, M. F., Huber, K. M. & Warren, S. T. The mGluR theory of fragile X mental retardation. Trends Neurosci. 27, 370–377 (2004). source
Not checked in the free run.
- cites [57] Osterweil, E. K., Krueger, D. D., Reinhold, K. & Bear, M. F. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. J. Neurosci. 30, 15616–15627 (2010). source
Not checked in the free run.
- cites [58] Dolen, G. et al. Correction of fragile X syndrome in mice. Neuron 56, 955–962 (2007). source
Not checked in the free run.
- Premisecitation
In Fmr1 knockout mice, activity-dependent maturation of excitatory thalamocortical synapses is dysregulated, causing persistence of silent NMDA-receptor-only synapses at times when they would normally express both NMDA and AMPA receptors.
“In Fmr1 knockout mice, this activity-dependent maturation of the excitatory thalamocortical synapses is dysregulated, resulting in a persistence of silent NMDA-receptor-only synapses at times during brain development when these synapses would normally express both NMDA and AMPA receptors63.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] Harlow, E. G. et al. Critical period plasticity is disrupted in the barrel cortex of Fmr1 knockout mice. Neuron 65, 385–398 (2010). source
Not checked in the free run.
- Premisecitation
Neuronal activity acutely promotes an increase in the interaction of neurexins and neuroligins across the synapse in an NMDA-receptor-dependent manner.
“Using this approach, neuronal activity was found to acutely promote an increase in the interaction of neurexins and neuroligins across the synapse in an NMDA-receptor-dependent manner44.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Thyagarajan, A. & Ting, A. Y. Imaging activity-dependent regulation of neurexin-neuroligin interactions using trans-synaptic enzymatic biotinylation. Cell 143, 456–469 (2010). source
Not checked in the free run.
- Premisecitation
TRIM3 ubiquitin ligase mediates activity-dependent degradation of Shank1 and GKAP through a ubiquitin-proteasome mechanism.
“The TRIM3 ubiquitin ligase mediates the activity-dependent degradation of Shank1 and another PSD-scaffolding protein GKAP, by a ubiquitin–proteasome dependent mechanism52.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Hung, A. Y., Sung, C. C., Brito, I. L. & Sheng, M. Degradation of postsynaptic scaffold GKAP and regulation of dendritic spine morphology by the TRIM3 ubiquitin ligase in rat hippocampal neurons. PLoS ONE 5, e9842 (2010). source
Not checked in the free run.
- Premisecitation
Knockout mice with deletions in Shank family genes show behaviours resembling those seen in ASD.
“Knockout mice with deletions in members of the Shank family of genes exhibit behaviours similar to those observed in ASD.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [47] Peca, J. et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472, 437–442 (2011). source
Not checked in the free run.
- cites [48] Schmeisser, M. J. et al. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 486, 256–260 (2012). source
Not checked in the free run.
- cites [49] Won, H. et al. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486, 261–265 (2012). References 47–49 demonstrate the role of Shanks in regulating excitatory neurotransmission. source
Not checked in the free run.
- Interpretationreasoning
Arc is almost certainly not the only FMRP target mediating effects on LTD, excitatory synapse number, and ASD.
“However, Arc is almost certainly not the only target of FMRP that mediates the effects of FMRP on LTD, excitatory synapse number and ASD.”
Quote in the paperSubstantial claim - Premisecitation
The route and dynamics of calcium entry into a neuron determine the program of activity-dependent gene expression that is activated.
“The route and dynamics of calcium entry into the neuron determines the program of activity-dependent gene expression that is activated24,25.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [24] Bading, H., Ginty, D. D. & Greenberg, M. E. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 260, 181–186 (1993). source
Not checked in the free run.
- cites [25] Dolmetsch, R. E., Pajvani, U., Fife, K., Spotts, J. M. & Greenberg, M. E. Signaling to the nucleus by an L-type calcium channel–calmodulin complex through the MAP kinase pathway. Science 294, 333–339 (2001). source
Not checked in the free run.
- Interpretationreasoning
Observations suggest a role for BDNF in TSC.
“the observations of BDNF's widespread role in nervous system development, that Bdnf transcription is robustly induced by neuronal activity and that BDNF regulates protein translation through inhibition of TSC1–TSC2, suggest a role for BDNF in tuberous sclerosis complex.”
Quote in the paperSubstantial claim - Premisecitation
Binding of growth factors to receptor tyrosine kinases leads to phosphorylation of the TSC complex and subsequent activation of mTOR, a positive regulator of protein synthesis.
“The binding of growth factors to receptor tyrosine kinases leads to phosphorylation of the TSC complex and subsequent activation of the mTOR, a positive regulator of protein synthesis67.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Han, J. M. & Sahin, M. TSC1/TSC2 signaling in the CNS. FEBS Lett. 585, 973–980 (2011). source
Not checked in the free run.
- Premisecitation
Stimulus-regulated phosphorylation or dephosphorylation of FMRP alters its ability to suppress mRNA translation.
“stimulus-regulated phosphorylation or dephosphorylation of FMRP alters its ability to suppress mRNA translation61,73–75.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [61] Niere, F., Wilkerson, J. R. & Huber, K. M. Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression. J. Neurosci. 32, 5924–5936 (2012). source
Not checked in the free run.
- cites [73] Ceman, S. et al. Phosphorylation influences the translation state of FMRP-associated polyribosomes. Hum. Mol. Genet. 12, 3295–3305 (2003). source
Not checked in the free run.
- cites [74] Narayanan, U. et al. FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. J. Neurosci. 27, 14349–14357 (2007). source
Not checked in the free run.
- cites [75] Muddashetty, R. S. et al. Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Mol. Cell 42, 673–688 (2011). source
Not checked in the free run.
- Interpretationcitation
The absence of AMPA receptors at these synapses may be due in part to dysregulation of Arc mRNA translation in Fmr1 knockout mice.
“The absence of AMPA receptors at these synapses may be due, in part, to the dysregulation of Arc mRNA translation that occurs in Fmr1 knockout mice.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] Harlow, E. G. et al. Critical period plasticity is disrupted in the barrel cortex of Fmr1 knockout mice. Neuron 65, 385–398 (2010). source
Not checked in the free run.
- Premisecitation
In excitatory neurons, activity-dependent gene transcription is mediated at least in part by calcium entry through L-type calcium channels.
“In excitatory neurons, activity-dependent gene transcription is mediated, at least in part, by calcium entry through L-type calcium channels25.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [25] Dolmetsch, R. E., Pajvani, U., Fife, K., Spotts, J. M. & Greenberg, M. E. Signaling to the nucleus by an L-type calcium channel–calmodulin complex through the MAP kinase pathway. Science 294, 333–339 (2001). source
Not checked in the free run.
- Interpretationreasoning
MEF2 restricts excitatory synapse number at least in part by activating Arc transcription.
“MEF2 seems to restrict excitatory synapse number, at least in part, by activating Arc transcription.”
Quote in the paperSubstantial claim - Premisecitation
Tsc2+/- mice have decreased translation of Arc mRNA compared to wild-type mice.
“Compared with wild-type mice, Tsc2+/− mice have decreased translation of Arc mRNA71.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [71] Auerbach, B. D., Osterweil, E. K. & Bear, M. F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480, 63–68 (2011). This paper shows that loss of function of either TSC1–TSC2 or FMRP disrupts activity-regulated mRNA translation and synaptic plasticity in opposite directions. source
Not checked in the free run.
- Premisecitation
Loss of function of TSC1 and TSC2 leads to deregulated activation of mTOR.
“Loss of function of TSC1 and TSC2 leads to deregulated activation of mTOR13,69.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [13] Kelleher, R. J. III & Bear, M. F. The autistic neuron: troubled translation? Cell 135, 401–406 (2008). source
Not checked in the free run.
- cites [69] Ehninger, D. et al. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nature Med. 14, 843–848 (2008). source
Not checked in the free run.
- Interpretationreasoning
TSC may result from dysregulation of these processes.
“suggesting that tuberous sclerosis complex may be a result of the dysregulation of these processes13,69.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [13] Kelleher, R. J. III & Bear, M. F. The autistic neuron: troubled translation? Cell 135, 401–406 (2008). source
Not checked in the free run.
- cites [69] Ehninger, D. et al. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nature Med. 14, 843–848 (2008). source
Not checked in the free run.
- Premisecitation
MEF2 controls a gene expression program that has a role in developmental synapse elimination.
“The transcription factor MEF2 controls a program of gene expression that has a role in developmental synapse elimination26,29,65,66.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [26] Flavell, S. W. et al. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311, 1008–1012 (2006). source
Not checked in the free run.
- cites [29] Flavell, S. W. et al. Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Neuron 60, 1022–1038 (2008). source
Not checked in the free run.
- cites [65] Barbosa, A. C. et al. MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function. Proc. Natl Acad. Sci. USA 105, 9391–9396 (2008). source
Not checked in the free run.
- cites [66] Pulipparacharuvil, S. et al. Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron 59, 621–633 (2008). source
Not checked in the free run.
- Premisecitation
Postnatal deletion of Tsc1 in hippocampal CA1 mouse neurons by viral Cre delivery leads to loss of mGluR-LTD.
“post-natal deletion of Tsc1 in hippocampal CA1 mouse neurons by viral delivery of Cre recombinase led to loss of mGluR–LTD72.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [72] Bateup, H. S., Takasaki, K. T., Saulnier, J. L., Denefrio, C. L. & Sabatini, B. L. Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function. J. Neurosci. 31, 8862–8869 (2011). source
Not checked in the free run.
- Interpretationcitation
The effects of MEF2 on synapse number may depend on FMRP.
“suggesting that the effects of MEF2 on synapse number may be FMRP dependent64.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [64] Pfeiffer, B. E. et al. Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2. Neuron 66, 191–197 (2010). source
Not checked in the free run.
- Interpretationnone given
ASD-associated mutations disrupt multiple features and components of the signalling network controlling activity-dependent gene transcription.
“Mutations associated with ASD disrupt multiple features and components of the signalling network that controls activity-dependent gene transcription.”
Quote in the paperSubstantial claim- Rests on an assumption: Neuronal activity regulates programs of gene expression in the nucleus that modulate synaptic development and plasticity.
- Interpretationnone given
TSC is the other main syndromic ASD that seems to result from dysregulation of activity-modulated mRNA translation.
“Tuberous sclerosis complex is the other main syndromic ASD that seems to be a consequence of a dysregulation of activity-modulated mRNA translation.”
Quote in the paperSubstantial claim - Interpretationreasoning
Arc may link MEF2 and FMRP.
“Arc may be the link between MEF2 and FMRP.”
Quote in the paperSubstantial claim - Interpretationreasoning
Once Arc transcription is induced, translation of Arc mRNA is kept in check by FMRP.
“Once Arc transcription is induced, translation of the Arc mRNA is kept in check by FMRP.”
Quote in the paperSubstantial claim - Premisecitation
Activated Akt phosphorylates TSC2, reducing its GAP activity for Rheb.
“Activated Akt phosphorylates TSC2, reducing its GTPase activating protein (GAP) activity for the Ras family GTPase, Rheb.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Han, J. M. & Sahin, M. TSC1/TSC2 signaling in the CNS. FEBS Lett. 585, 973–980 (2011). source
Not checked in the free run.
- Premisecitation
PTEN catalyses dephosphorylation of PtdIns(3,4,5)P3 to generate PtdIns(4,5)P2, antagonizing PI(3)K activity.
“The lipid phosphatase PTEN catalyses the dephosphorylation of PtdIns(3,4,5)P3 at the 3′ position to generate PtdIns(4,5)P2 thus antagonizing the activity of PI(3)K70.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [70] Zhou, J. & Parada, L. F. PTEN signaling in autism spectrum disorders. Curr. Opin. Neurobiol. 22, 873–879 (2012). source
Not checked in the free run.
- Interpretationreasoning
Signalling by TSC1-TSC2 downstream of other neurotrophic factors is likely to contribute to TSC.
“Signalling by TSC1–TSC2 downstream of other neurotrophic factors is also likely to contribute to tuberous sclerosis complex.”
Quote in the paperNot a substantial claim - Interpretationreasoning
ASD candidate genes and FMRP may function in overlapping pathways.
“This suggests that these ASD candidate genes and FMRP may function in overlapping pathways.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [23] Bhakar, A. L., Dolen, G. & Bear, M. F. The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci. 35, 417–443 (2012). source
Not checked in the free run.
- cites [33] Darnell, J. C. et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247–261 (2011). source
Not checked in the free run.
- Premisecitation
Activity-dependent gene expression was altered in Timothy syndrome neurons compared to controls, with more than two hundred genes showing altered expression after membrane depolarization.
“Activity-dependent gene expression was also altered in the Timothy syndrome neurons, compared with control neurons, with more than two hundred genes displaying altered expression following membrane depolarization78.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] Pasca, S. P. et al. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nature Med. 17, 1657–1662 (2011). source
Not checked in the free run.
- Premisecitation
Mutations in CACNA1C, which encodes the α1 pore-forming subunit of the L-type calcium channel Cav1.2, are associated with multiple neuropsychiatric disorders including ASD.
“Mutations in CACNA1C, which encodes the α1 pore-forming subunit of the L-type calcium channel Cav1.2, has been associated with multiple neuropsychiatric disorders, including ASD76.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [76] Bhat, S. et al. CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease. Prog. Neurobiol. 99, 1–14 (2012). source
Not checked in the free run.
- Premisecitation
Hippocampal neurons from Mecp2 knockout mice, both in culture and in vivo, have reduced glutamatergic synapse number and density with reduced excitatory synapse strength.
“Hippocampal neurons from Mecp2 knockout mice, both grown in culture and in vivo, have reduced glutamatergic synapse number and density with reduced excitatory synapse strength87.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [87] Chao, H. T., Zoghbi, H. Y. & Rosenmund, C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56, 58–65 (2007). source
Not checked in the free run.
- Premisecitation
Timothy syndrome, characterized by cardiac arrhythmia, congenital heart disease, immune deficiency, intermittent hypoglycaemia, global development delay, and ASD, is caused by a missense mutation in CACNA1C.
“Timothy syndrome, a disorder characterized by cardiac arrhythmia, congenital heart disease, immune deficiency, intermittent hypoglycaemia, global development delay and ASD, is caused by a missense mutation in CACNA1C31.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] Splawski, I. et al. CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19–31 (2004). source
Not checked in the free run.
- Interpretationreasoning
Rett syndrome may be due to a defect in activity-dependent chromatin regulation or gene transcription controlling synaptic development, plasticity, and behaviour.
“suggests that Rett syndrome may be due to a defect in the process of activity-dependent chromatin regulation or gene transcription that controls synaptic development, plasticity and behaviour.”
Quote in the paperSubstantial claim- Rests on an assumption: Mutations in MECP2 lead to Rett syndrome, an ASD characterized by impaired language development, loss of social engagement, stereotyped hand movements, seizures, and motor-system disabilities.
- Interpretationcitation
MECP2 may have a histone-like role in regulating chromatin structure and gene expression.
“These findings suggest that MECP2 may have a histone-like role in regulating chromatin structure and gene expression79,80.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [79] Skene, P. J. et al. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell 37, 457–468 (2010). source
Not checked in the free run.
- cites [80] Cohen, S. et al. Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72, 72–85 (2011). This paper demonstrates the importance of activity-dependent regulation of MECP2 in the control of synapse development and behaviour. source
Not checked in the free run.
- Rests on an assumption: MECP2 expression in mature neurons is similar to that of core histones, and MECP2 is bound broadly across the genome.
- Interpretationcitation
ASD phenotypes associated with Timothy syndrome may result from deregulation of activity-dependent gene transcription.
“These findings raise the possibility that the ASD phenotypes associated with Timothy syndrome may be the result of the deregulation of activity-dependent gene transcription.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] Pasca, S. P. et al. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nature Med. 17, 1657–1662 (2011). source
Not checked in the free run.
- Premisecitation
Neurons from mice with maternal Ube3A deletion express increased levels of Arc protein.
“neurons from these mice express increased levels of Arc protein.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Greer, P. L. et al. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating Arc. Cell 140, 704–716 (2010). This study provides insight into the molecular mechanisms underlying Angelman syndrome and the role of neuronal activity in regulating UBE3A and its targets. source
Not checked in the free run.
- Interpretationcitation
Activity-dependent phosphorylation of MECP2 may mediate a genome-wide chromatin response to neuronal activity.
“raising the possibility that activity-dependent phosphorylation of MECP2 mediates a genome-wide chromatin response to neuronal activity80.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [80] Cohen, S. et al. Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72, 72–85 (2011). This paper demonstrates the importance of activity-dependent regulation of MECP2 in the control of synapse development and behaviour. source
Not checked in the free run.
- Premisecitation
Ube3A expression is up-regulated by neuronal activity.
“Ube3A expression is up-regulated by neuronal activity”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Greer, P. L. et al. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating Arc. Cell 140, 704–716 (2010). This study provides insight into the molecular mechanisms underlying Angelman syndrome and the role of neuronal activity in regulating UBE3A and its targets. source
Not checked in the free run.
- Premisecitation
Extensive analysis of activity-dependent gene transcription in wild-type and MECP2 Ser421Ala knock-in neurons failed to detect any effect of the Ser421Ala mutation.
“extensive analysis of activity-dependent gene transcription in wild-type and MECP2 Ser421Ala knock-in neurons failed to detect any effect of the Ser421Ala mutation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [80] Cohen, S. et al. Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72, 72–85 (2011). This paper demonstrates the importance of activity-dependent regulation of MECP2 in the control of synapse development and behaviour. source
Not checked in the free run.
- Premisecitation
In Mecp2 knockout mice, initial development and refinement of the retinogeniculate circuit proceeds without impairment during a phase not dependent on visual experience.
“In Mecp2 knockout mice, the initial development and refinement of the retinogeniculate circuit proceeds without impairment, during a phase of development that does not depend on visual experience.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] Noutel, J., Hong, Y. K., Leu, B., Kang, E. & Chen, C. Experience-dependent retinogeniculate synapse remodeling is abnormal in MeCP2-deficient mice. Neuron 70, 35–42 (2011). source
Not checked in the free run.
- Interpretationcitation
UBE3A, FMRP, and TSC mutations may converge in ASD aetiology.
“suggesting a possible convergence point for UBE3A, FMRP and TSC mutations in the aetiology of ASD.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Greer, P. L. et al. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating Arc. Cell 140, 704–716 (2010). This study provides insight into the molecular mechanisms underlying Angelman syndrome and the role of neuronal activity in regulating UBE3A and its targets. source
Not checked in the free run.
- Premisecitation
Sensory experience-regulated neocortical plasticity is defective in Ube3A mutant mice.
“In addition, sensory experience-regulated neocortical plasticity is defective in Ube3A mutant mice91.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [91] Yashiro, K. et al. Ube3a is required for experience-dependent maturation of the neocortex. Nature Neurosci. 12, 777–783 (2009). source
Not checked in the free run.
- Premisecitation
Experience-dependent maturation of excitatory circuits in the visual cortex is substantially impaired in maternal Ube3A deletion mice.
“Experience-dependent maturation of excitatory circuits in the visual cortex is substantially impaired in these same mice.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [91] Yashiro, K. et al. Ube3a is required for experience-dependent maturation of the neocortex. Nature Neurosci. 12, 777–783 (2009). source
Not checked in the free run.
- Premisecitation
One of the best-studied targets of UBE3A is the neuronal activity-regulated protein Arc.
“one of the best-studied targets of UBE3A is the neuronal activity-regulated protein Arc89”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Greer, P. L. et al. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating Arc. Cell 140, 704–716 (2010). This study provides insight into the molecular mechanisms underlying Angelman syndrome and the role of neuronal activity in regulating UBE3A and its targets. source
Not checked in the free run.
- Interpretationreasoning
Fine-tuning UBE3A expression may be important for normal cognitive function.
“Support for the idea that fine-tuning the level of UBE3A expression may be important for normal cognitive function comes from the observation that the paternally inherited allele of UBE3A is imprinted, and specifically silenced in the brain.”
Quote in the paperSubstantial claim- Rests on an assumption: The paternally inherited allele of UBE3A is imprinted and specifically silenced in the brain.
- Premisecitation
Ser421Ala knock-in mice had deficits in their response to new objects or mice.
“Behaviourally, the Ser421Ala knock-in mice had deficits in their response to new objects or mice80.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [80] Cohen, S. et al. Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72, 72–85 (2011). This paper demonstrates the importance of activity-dependent regulation of MECP2 in the control of synapse development and behaviour. source
Not checked in the free run.
- Premisecitation
Inhibitory drive onto neocortical pyramidal neurons is impaired due to defective presynaptic vesicle cycling in interneuron populations.
“inhibitory drive onto neocortical pyramidal neurons is impaired owing to defective presynaptic vesicle cycling in interneuron populations92.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92] Wallace, M. L., Burette, A. C., Weinberg, R. J. & Philpot, B. D. Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects. Neuron 74, 793–800 (2012). source
Not checked in the free run.
- Premisecitation
Neuronal activity induces phosphorylation of MECP2 at Ser421 broadly across the genome.
“Neuronal activity induces the phosphorylation of MECP2 at Ser421 (refs 81–83) broadly across the genome”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [81] Chen, W. G. et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302, 885–889 (2003). source
Not checked in the free run.
- cites [82] Zhou, Z. et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52, 255–269 (2006). source
Not checked in the free run.
- cites [83] Deng, J. V. et al. MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants. Nature Neurosci. 13, 1128–1136 (2010). source
Not checked in the free run.
- Premisecitation
MECP2 is required for experience-dependent synaptic remodelling of the retinogeniculate synapse.
“MECP2 has recently been shown to be required for experience-dependent synaptic remodelling of the retinogeniculate synapse85.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] Noutel, J., Hong, Y. K., Leu, B., Kang, E. & Chen, C. Experience-dependent retinogeniculate synapse remodeling is abnormal in MeCP2-deficient mice. Neuron 70, 35–42 (2011). source
Not checked in the free run.
- Interpretationreasoning
MECP2 may have a unique function in neurons.
“suggesting that MECP2 may have a unique function in neurons.”
Quote in the paperNot a substantial claim- Rests on an assumption: MECP2 expression in post-mitotic neurons is about tenfold higher than in other cell types.
- Premisecitation
Excitatory drive onto neocortical pyramidal neurons is also diminished, but to a less severe extent.
“Excitatory drive onto neocortical pyramidal neurons is also diminished, but to a less severe extent92.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92] Wallace, M. L., Burette, A. C., Weinberg, R. J. & Philpot, B. D. Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects. Neuron 74, 793–800 (2012). source
Not checked in the free run.
- Interpretationnone given
Multiple studies provide evidence that mutations causing ASD alter how sensory experience modifies synapses, via local changes in protein phosphorylation at synapses, control of mRNA translation, or regulation of gene transcription.
“A variety of studies now provide evidence that mutations that lead to ASD affect how sensory experience modifies synapses, either through local changes in protein phosphorylation at the synapse, the control of mRNA translation or the regulation of gene transcription.”
Quote in the paperNot a substantial claim - Premisecitation
Reference 80 demonstrates that activity-dependent regulation of MECP2 is important for controlling synapse development and behaviour.
“This paper demonstrates the importance of activity-dependent regulation of MECP2 in the control of synapse development and behaviour.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [80] Cohen, S. et al. Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72, 72–85 (2011). This paper demonstrates the importance of activity-dependent regulation of MECP2 in the control of synapse development and behaviour. source
Not checked in the free run.
- Interpretationreasoning
Networks of activity-dependent signalling that regulate synapse development, function and plasticity may be substantially involved in the pathogenesis of autism spectrum disorder.
“The studies reviewed in this manuscript suggest that dysregulation of activity-dependent signalling networks that control synapse development, function and plasticity may contribute significantly to ASD pathogenesis.”
Quote in the paperSubstantial claim - Premisecitation
Mouse models of Rett syndrome, Angelman syndrome, tuberous sclerosis complex, Fragile X syndrome, and rare SHANK mutations have provided strong evidence that interventions of a genetic or pharmacological nature can improve ASD phenotypes.
“Several mouse models of ASD, including those of Rett syndrome96,97, Angelman syndrome98, tuberous sclerosis complex71, and Fragile X23 syndrome, and mouse models of rare mutations in SHANK proteins49, have provided convincing evidence that ASD phenotypes can be improved by genetic or pharmacological interventions”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [96] Guy, J., Gan, J., Selfridge, J., Cobb, S. & Bird, A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143–1147 (2007). source
Not checked in the free run.
- cites [97] Giacometti, E., Luikenhuis, S., Beard, C. & Jaenisch, R. Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc. Natl Acad. Sci. USA 104, 1931–1936 (2007). source
Not checked in the free run.
- cites [98] van Woerden, G. M. et al. Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of αCaMKII inhibitory phosphorylation. Nature Neurosci. 10, 280–282 (2007). source
Not checked in the free run.
- cites [71] Auerbach, B. D., Osterweil, E. K. & Bear, M. F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480, 63–68 (2011). This paper shows that loss of function of either TSC1–TSC2 or FMRP disrupts activity-regulated mRNA translation and synaptic plasticity in opposite directions. source
Not checked in the free run.
- Premisecitation
Reference 71 shows that loss of function of TSC1-TSC2 or FMRP disrupts activity-regulated mRNA translation and synaptic plasticity in opposite directions.
“This paper shows that loss of function of either TSC1–TSC2 or FMRP disrupt activity-regulated mRNA translation and synaptic plasticity in opposite directions.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [71] Auerbach, B. D., Osterweil, E. K. & Bear, M. F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480, 63–68 (2011). This paper shows that loss of function of either TSC1–TSC2 or FMRP disrupts activity-regulated mRNA translation and synaptic plasticity in opposite directions. source
Not checked in the free run.
- Premisecitation
UBE3A mediates ubiquitination and degradation of Arc.
“UBE3A was found to mediate the ubiquitination and degradation of Arc89.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Greer, P. L. et al. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating Arc. Cell 140, 704–716 (2010). This study provides insight into the molecular mechanisms underlying Angelman syndrome and the role of neuronal activity in regulating UBE3A and its targets. source
Not checked in the free run.
- May combine two claims. 82
- Classified as probably not a substantial claim. 11
May combine two claims.
PremisecitationASD is polygenic, with recent studies of de novo exonic mutations suggesting involvement of as many as 400 to 1,000 genetic loci.
“ASD is polygenic in aetiology; recent studies of de novo exonic mutations suggest the involvement of as many as 400 to 1,000 genetic loci in ASD9.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] O'Roak, B. J. et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nature Genet. 43, 585–589 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationSynaptic stimulation induces specific changes in mRNA translation near synapses and sends signals to the nucleus that induce gene transcription programs controlling synaptic maturation and function.
“Synaptic stimulation both induces specific changes in messenger RNA translation near synapses and sends signals to the nucleus to induce gene transcription programs that control synaptic maturation and function.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [12] Greer, P. L. & Greenberg, M. E. From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron 59, 846–860 (2008). source
Not checked in the free run.
- cites [15] Cohen, S. & Greenberg, M. E. Communication between the synapse and the nucleus in neuronal development, plasticity, and disease. Annu. Rev. Cell Dev. Biol. 24, 183–209 (2008). source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
InterpretationreasoningMany genes implicated in ASD could function in convergent molecular pathways, allowing formulation of specific mechanistic hypotheses that could explain significant portions of ASD.
“However, as already suggested, many of the genes implicated in ASD could function in convergent molecular pathways, allowing for the formulation of specific mechanistic hypotheses that could explain significant portions of ASD.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMost features of ASD appear in the first few years of life, a period when sensory experience modifies excitatory synapse maturation and elimination and promotes inhibitory synapse development.
“Most of these features of ASD manifest in the first few years of life, at the time of brain development when sensory experience is modifying excitatory synapse maturation and elimination, and promoting the development of inhibitory synapses3.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Flavell, S. W. & Greenberg, M. E. Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. Annu. Rev. Neurosci. 31, 563–590 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationNeuronal activity-dependent pathways are crucial for learning and memory and adaptive behavioural responses.
“These neuronal activity-dependent pathways are crucial to learning and memory and for adaptive behavioural responses11–13.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [11] Kandel, E. R. The molecular biology of memory storage: a dialogue between genes and synapses. Science 294, 1030–1038 (2001). source
Not checked in the free run.
- cites [12] Greer, P. L. & Greenberg, M. E. From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron 59, 846–860 (2008). source
Not checked in the free run.
- cites [13] Kelleher, R. J. III & Bear, M. F. The autistic neuron: troubled translation? Cell 135, 401–406 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationNeuronal activity modifies synaptic molecules post-translationally, promotes local dendritic protein synthesis, and activates gene transcription, thereby regulating synaptic function and enabling circuits to adapt to experience.
“Neuronal activity induces the post-translational modification of synaptic molecules, promotes localized protein synthesis within dendrites and activates gene transcription, thereby regulating synaptic function and allowing neuronal circuits to respond dynamically to experience.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [11] Kandel, E. R. The molecular biology of memory storage: a dialogue between genes and synapses. Science 294, 1030–1038 (2001). source
Not checked in the free run.
- cites [12] Greer, P. L. & Greenberg, M. E. From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron 59, 846–860 (2008). source
Not checked in the free run.
- cites [13] Kelleher, R. J. III & Bear, M. F. The autistic neuron: troubled translation? Cell 135, 401–406 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationMutations in RSK2, CBP, MECP2, and UBE3A cause Coffin-Lowry syndrome, Rubinstein-Taybi syndrome, Rett syndrome and Angelman syndrome, respectively.
“Likewise, mutations in RSK2, CBP, the methyl-binding protein MECP2, and the ubiquitin ligase UBE3A are causes of Coffin–Lowry syndrome, Rubinstein–Taybi syndrome, Rett syndrome and Angelman syndrome, respectively3.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Flavell, S. W. & Greenberg, M. E. Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. Annu. Rev. Neurosci. 31, 563–590 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationKnock-in mice with the ASD-associated missense mutation Nlgn3(R704C) show decreased AMPA receptor-mediated synaptic transmission in the hippocampus, but no alteration in NMDA or GABA-receptor mediated neurotransmission.
“Knock-in mice with another ASD-associated missense mutation, Nlgn3(R704C) displayed a decrease in AMPA receptor-mediated synaptic transmission in the hippocampus, but no alteration in NMDA or GABA (γ-aminobutyric acid)-receptor mediated neurotransmission39.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [39] Etherton, M. R., Tabuchi, K., Sharma, M., Ko, J. & Sudhof, T. C. An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus. EMBO J. 30, 2908–2919 (2011). source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningIt has been proposed that ASD may result, at least in part, from disruption of activity-dependent signalling networks that control gene transcription.
“Only about 3% of the neuronal transcriptome is altered when the membrane is depolarized, but a higher percentage of the genes that are implicated in ASD have been shown to be regulated by neuronal activity, it has been proposed, therefore, that ASD may result, at least in part, from the disruption of the activity-dependent signalling networks that control gene transcription34,35.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [34] Morrow, E. M. et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 321, 218–223 (2008). This paper provides evidence for the hypothesis that genetic mutations associated with ASD may disrupt activity-dependent gene expression programs. source
Not checked in the free run.
- cites [35] Chahrour, M. H. et al. Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism. PLoS Genet. 8, e1002635 (2012). source
Not checked in the free run.
May combine two claims.
PremisecitationNrxn1 knock-out mice have defects in miniature EPSC frequency and evoked postsynaptic potentials, but no change in inhibitory neurotransmission in the hippocampus.
“Nrxn1 knock-out mice have defects in miniature excitatory postsynaptic current (EPSC) frequency and evoked postsynaptic potentials, but show no change in inhibitory neurotransmission in the hippocampus40.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] Etherton, M. R., Blaiss, C. A., Powell, C. M. & Sudhof, T. C. Mouse neurexin-1α deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc. Natl Acad. Sci. USA 106, 17998–18003 (2009). source
Not checked in the free run.
May combine two claims.
PremisecitationSeveral neuroligin mutations found in individuals with ASD have been modelled in mice, and these mice show alterations in excitatory or inhibitory neurotransmission.
“Several of the neuroligin mutations found in individuals with ASD have been modelled in mice, and these mice have been shown to have alterations in excitatory or inhibitory neurotransmission.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [38] Tabuchi, K. et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71–76 (2007). source
Not checked in the free run.
- cites [39] Etherton, M. R., Tabuchi, K., Sharma, M., Ko, J. & Sudhof, T. C. An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus. EMBO J. 30, 2908–2919 (2011). source
Not checked in the free run.
- cites [40] Etherton, M. R., Blaiss, C. A., Powell, C. M. & Sudhof, T. C. Mouse neurexin-1α deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc. Natl Acad. Sci. USA 106, 17998–18003 (2009). source
Not checked in the free run.
May combine two claims.
InterpretationcitationThis suggests a role for neuroligins in experience-regulated learning and memory that may be altered by ASD-associated mutations in NLGN1.
“This suggests a role for neuroligins in experience-regulated learning and memory which may be altered by ASD-associated mutations in NLGN1.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe CGG expansion occurs in the 5′ untranslated region of FMRP mRNA, decreasing FMRP mRNA translation and reducing FMRP levels in neurons.
“The CGG expansion occurs within the 5′ untranslated region of the FMRP mRNA, resulting in decreased translation of the FMRP mRNA and a decrease in the amount of FMRP expressed in neurons.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Bhakar, A. L., Dolen, G. & Bear, M. F. The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci. 35, 417–443 (2012). source
Not checked in the free run.
May combine two claims.
PremisecitationOnly about 3% of the neuronal transcriptome is altered by membrane depolarization, but a higher percentage of ASD-implicated genes are regulated by neuronal activity.
“Only about 3% of the neuronal transcriptome is altered when the membrane is depolarized, but a higher percentage of the genes that are implicated in ASD have been shown to be regulated by neuronal activity, it has been proposed, therefore, that ASD may result, at least in part, from the disruption of the activity-dependent signalling networks that control gene transcription34,35.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [34] Morrow, E. M. et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 321, 218–223 (2008). This paper provides evidence for the hypothesis that genetic mutations associated with ASD may disrupt activity-dependent gene expression programs. source
Not checked in the free run.
- cites [35] Chahrour, M. H. et al. Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism. PLoS Genet. 8, e1002635 (2012). source
Not checked in the free run.
May combine two claims.
PremisecitationKnockdown of Nlgn1 in the amygdala of adult rats led to selective reduction of NMDA-receptor-mediated currents and impairments in LTP and storage of associative fear memory.
“In another study42, knockdown of Nlgn1, delivered by a viral vector, in the amygdala of adult rats led to the selective reduction of NMDA-receptor-mediated currents, and impairments in LTP and in the storage of associative fear memory.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42] Kim, J. et al. Neuroligin-1 is required for normal expression of LTP and associative fear memory in the amygdala of adult animals. Proc. Natl Acad. Sci. USA 105, 9087–9092 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationParticular neuroligin family members localize specifically to inhibitory or excitatory synapses, suggesting individual neuroligins may specify the formation or function of excitatory and inhibitory synapses.
“Particular neuroligin family members are localized specifically to inhibitory or excitatory synapses, suggesting that individual neuroligins may play a part in specifying the formation or function of excitatory and inhibitory synapses.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [16] Missler, M., Sudhof, T. C. & Biederer, T. Synaptic cell adhesion. Cold Spring Harb. Perspect. Biol. 4, a005694 (2012). source
Not checked in the free run.
- cites [37] Sudhof, T. C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903–911 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationFragile X syndrome is characterized by macroorchidism, connective-tissue disease, motor abnormalities, language deficits and impaired social interactions, and is the leading cause of inherited intellectual disability and ASD.
“For example, Fragile X syndrome — characterized by macroorchidism, connective-tissue disease, motor abnormalities, language deficits and impaired social interactions — is the leading cause of inherited intellectual disability and ASD23.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Bhakar, A. L., Dolen, G. & Bear, M. F. The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci. 35, 417–443 (2012). source
Not checked in the free run.
May combine two claims.
PremisereasoningThese syndromic disorders are caused by single gene mutations and have readily diagnosable phenotypes, so their mechanistic understanding is more advanced than for most ASD.
“These syndromic disorders are caused by single gene mutations and have phenotypes that have allowed the disorder to be readily diagnosed; thus, the mechanistic understanding of these syndromes is more advanced than for most ASD.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningBecause these proteins regulate synaptic responses to experience and are themselves modulated by neuronal activity, this supports the hypothesis that ASD may result from disruption of normal activity-dependent synapse development.
“The fact that these proteins have key roles in regulating synaptic responses to experience, and are themselves modulated by neuronal activity supports the hypothesis that ASD may result from the disruption of the normal process of activity-dependent synapse development (Fig. 2).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationFMRP modulates the rate of translational elongation of mRNAs encoding synaptic proteins, suggesting that reduced FMRP in Fragile X syndrome may dysregulate synaptic protein expression through impaired translational control.
“FMRP has recently been reported to modulate the rate of translational elongation of mRNAs that encode synaptic proteins33, suggesting that the decrease in FMRP expression that occurs in Fragile X syndrome may result in the dysregulation of synaptic protein expression owing to an impairment in translational control23.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [33] Darnell, J. C. et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247–261 (2011). source
Not checked in the free run.
- cites [23] Bhakar, A. L., Dolen, G. & Bear, M. F. The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci. 35, 417–443 (2012). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningBecause de novo mutations in coding regions occur with reasonable frequency and do not necessarily cause a deleterious phenotype, additional evidence is required before each mutation can unequivocally be said to contribute to ASD.
“As de novo mutations within gene-coding regions occur with reasonable frequency and do not necessarily result in a deleterious phenotype, additional evidence is required before each of these mutations can unequivocally be said to contribute to ASD.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationNeuroligins are postsynaptic membrane proteins that function as neurexin receptors and, together with neurexins, modulate synapse formation and function.
“Neuroligins are postsynaptic membrane proteins that function as neurexin receptors and, working together with neurexins, modulate the formation and function of synapses16,37.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [16] Missler, M., Sudhof, T. C. & Biederer, T. Synaptic cell adhesion. Cold Spring Harb. Perspect. Biol. 4, a005694 (2012). source
Not checked in the free run.
- cites [37] Sudhof, T. C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903–911 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationRare mutations in NLGN4, NLGN3, NRXN1, SHANK2, SHANK3, and CNTNAP2 have been identified in multiple individuals with ASD, suggesting these mutations contribute to the disorder.
“More subtle, rare mutations in NLGN4, NLGN3, NRXN1, SHANK2, SHANK3, CNTNAP2 (ref. 5) have also been identified in multiple individuals with ASD, suggesting that these mutations also contribute these disorders.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] State, M. W. & Levitt, P. The conundrums of understanding genetic risks for autism spectrum disorders. Nature Neurosci. 14, 1499–1506 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationThese Nlgn3(R451C) knock-in mice also have enhanced inhibitory neurotransmission with no alterations in excitatory neurotransmission, resulting in a defect in excitatory-inhibitory balance.
“These knock-in mice also have enhanced inhibitory neurotransmission with no alterations in excitatory neurotransmission, resulting in a defect in excitatory–inhibitory balance in the brain38.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [38] Tabuchi, K. et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71–76 (2007). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThese studies indicate that particular ASD mutations in neurexins or neuroligins disrupt excitatory or inhibitory neurotransmission in specific ways and suggest that modelling ASD-associated mutations in mice will be important for elucidating how each mutation affects synaptic function and gives rise to ASD.
“These studies indicate that particular ASD mutations in neurexins or neuroligins disrupt excitatory or inhibitory neurotransmission in the brain in specific ways and suggest that modelling ASD-associated mutations in mice will be important for elucidating how each mutation affects synaptic function and give rise to ASD.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn cultured rodent neurons, overexpression of Nlgn1 increases the number of functional excitatory synapses, an effect dependent on NMDA receptors and activity-regulated CaMKII downstream of NMDA receptor activation.
“In cultured neurons of rodents, overexpression of Nlgn1 increases the number of functional excitatory synapses, an effect that is dependent on NMDA receptors, as well as activity-regulated CaMKII that functions downstream of NMDA receptor activation to regulate of synaptic plasticity41.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [41] Chubykin, A. A. et al. Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 54, 919–931 (2007). This study reports the crucial role for neuroligins in activity-dependent synapse maturation and how this pathway is dysregulated by ASD-associated mutations in neuroligin. source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThese findings suggest that neuroligins and neurexins modulate activity-dependent synaptic remodelling and long-term memory, and that ASD-associated mutations in neuroligins or neurexins may disrupt these processes.
“Taken together, these findings suggest that neuroligins and neurexins modulate activity-dependent synaptic remodelling and long-term memory, and that ASD-associated mutations in neuroligins or neurexins may disrupt these processes.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationDisruption of this activity-regulated enhancement impaired recruitment of AMPA receptors to the synaptic membrane, altering synaptic function.
“Disruption of this activity-regulated enhancement impaired the recruitment of AMPA receptors to the synaptic membrane, thereby altering synaptic function44.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Thyagarajan, A. & Ting, A. Y. Imaging activity-dependent regulation of neurexin-neuroligin interactions using trans-synaptic enzymatic biotinylation. Cell 143, 456–469 (2010). source
Not checked in the free run.
May combine two claims.
PremisecitationNeuronal activity induces insertion of neurexin and neuroligin into the synaptic membrane and suppresses their internalization, leading to an overall increase in trans-synaptic neurexin-neuroligin interaction.
“Neuronal activity induced both the insertion of neurexin and neuroligin into the synaptic membrane and suppressed internalization of neurexin and neuroligin from the synaptic membrane, leading to an overall increase in the trans-synaptic neurexin–neuroligin interaction.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Thyagarajan, A. & Ting, A. Y. Imaging activity-dependent regulation of neurexin-neuroligin interactions using trans-synaptic enzymatic biotinylation. Cell 143, 456–469 (2010). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningUnder normal conditions, FMRP suppresses mGluR-dependent protein synthesis and LTD.
“suggesting that under normal conditions FMRP suppresses mGluR-dependent protein synthesis and LTD55.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] Huber, K. M., Gallagher, S. M., Warren, S. T. & Bear, M. F. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl Acad. Sci. USA 99, 7746–7750 (2002). source
Not checked in the free run.
May combine two claims.
PremisecitationFmr1 knockout mice show abnormally high protein synthesis and enhanced LTD in response to mGluR stimulation.
“Fmr1 knockout mice exhibit abnormally high levels of protein synthesis and enhanced LTD in response to mGluR stimulation”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] Huber, K. M., Gallagher, S. M., Warren, S. T. & Bear, M. F. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl Acad. Sci. USA 99, 7746–7750 (2002). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningShank family proteins modulate excitatory synapse function, and mutations in their genes might contribute to ASD.
“Taken together, these studies have revealed how the Shank family of proteins modulate excitatory synapse function and begin to explain how mutations in the genes that encode them might lead to ASD.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningShank proteins control synaptic function and plasticity, and their mutation might contribute to autism spectrum phenotypes.
“Taken together, these studies begin to explain how Shank proteins control synaptic function and plasticity, and how their mutation might contribute to autism spectrum phenotypes.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationNeuronal activity controls alternative splicing of neurexin mRNA, which changes trans-synaptic signalling and presynaptic differentiation.
“Neuronal activity also regulates alternative splicing of neurexin mRNA and, thus, alters trans-synaptic signalling and presynaptic differentiation45.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] Iijima, T. et al. SAM68 regulates neuronal activity-dependent alternative splicing of neurexin-1. Cell 147, 1601–1614 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationIn Fmr1 knockout mice, dynamic translation of Arc mRNA in response to stimulation is impaired, and basal Arc protein level in dendrites is elevated.
“In Fmr1 knockout mice, the dynamic translation of Arc mRNA in response to stimulation is impaired59,61, and the basal level of the Arc protein in dendrites is elevated61.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [59] Park, S. et al. Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD. Neuron 59, 70–83 (2008). source
Not checked in the free run.
- cites [61] Niere, F., Wilkerson, J. R. & Huber, K. M. Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression. J. Neurosci. 32, 5924–5936 (2012). source
Not checked in the free run.
May combine two claims.
PremisecitationThe interaction between neurexins and neuroligins is regulated by neuronal activity, providing further evidence that mutations causing ASD might disrupt activity-dependent processes controlling synaptic function.
“The interaction between neurexins and neuroligins is regulated by neuronal activity, providing further evidence that mutations that cause ASD might be disrupting activity-dependent processes that control synaptic function.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Thyagarajan, A. & Ting, A. Y. Imaging activity-dependent regulation of neurexin-neuroligin interactions using trans-synaptic enzymatic biotinylation. Cell 143, 456–469 (2010). source
Not checked in the free run.
May combine two claims.
PremisecitationShank2 knockout mice show defects in NMDA-receptor-dependent excitatory neurotransmission and synaptic plasticity in the hippocampus.
“Shank2 knockout mice models show defects in NMDA-receptor-dependent excitatory neurotransmission and synaptic plasticity in the hippocampus48,49.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [48] Schmeisser, M. J. et al. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 486, 256–260 (2012). source
Not checked in the free run.
- cites [49] Won, H. et al. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486, 261–265 (2012). References 47–49 demonstrate the role of Shanks in regulating excitatory neurotransmission. source
Not checked in the free run.
May combine two claims.
PremisecitationShank3 knockout mice have social interaction deficits and repetitive behaviours such as excessive grooming that cause self-injury.
“Shank3 knockout mice have deficits in social interactions and engage in repetitive behaviours, such as excessive grooming, that lead to self injury47.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Peca, J. et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472, 437–442 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationShank proteins act as scaffolds in the postsynaptic density of excitatory synapses and control the organization of postsynaptic signalling complexes and synapse morphology and function.
“Shank proteins function as scaffolds in the PSD of excitatory synapses that regulate the organization of postsynaptic signalling complexes, as well as the morphology and function of synapses17–19.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [17] Naisbitt, S. et al. Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron 23, 569–582 (1999). source
Not checked in the free run.
- cites [18] Sala, C. et al. Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron 31, 115–130 (2001). source
Not checked in the free run.
- cites [19] Sheng, M. & Kim, E. The postsynaptic organization of synapses. Cold Spring Harb. Perspect. Biol. 3, a005678 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationTranslation of Arc mRNA is enhanced during and crucial for mGluR-dependent LTD.
“Translation of Arc mRNA is enhanced during, and crucial for, mGluR-dependent LTD59,60.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [59] Park, S. et al. Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD. Neuron 59, 70–83 (2008). source
Not checked in the free run.
- cites [60] Waung, M. W., Pfeiffer, B. E., Nosyreva, E. D., Ronesi, J. A. & Huber, K. M. Rapid translation of Arc/Arg3.1 selectively mediates mGluR-dependent LTD through persistent increases in AMPAR endocytosis rate. Neuron 59, 84–97 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationShank2 knockout mice show abnormalities in motor behaviour, vocalization, and socialization, which are phenotypes typical of ASD.
“mice lacking Shank2 have abnormalities in motor behaviour, vocalization and socialization — phenotypes typically observed in ASD48,49.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [48] Schmeisser, M. J. et al. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 486, 256–260 (2012). source
Not checked in the free run.
- cites [49] Won, H. et al. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486, 261–265 (2012). References 47–49 demonstrate the role of Shanks in regulating excitatory neurotransmission. source
Not checked in the free run.
May combine two claims.
InterpretationcitationAbnormally high Arc expression in Fmr1 knockout mice may be responsible for enhanced mGluR-LTD and may explain why their LTD is independent of new mRNA translation.
“This abnormally high level of Arc expression in Fmr1 knockout mice may be responsible for the enhanced mGluR–LTD observed in these animals and might explain, in part, why their LTD is independent of new mRNA translation62.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [62] Hou, L. et al. Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression. Neuron 51, 441–454 (2006). source
Not checked in the free run.
May combine two claims.
PremisecitationIn mice, retrieval of fear memory leads to polyubiquitination and degradation of Shank proteins and correlates with a requirement for protein degradation in memory extinction.
“In mice, the retrieval of fear memory was found to lead to the polyubiquitination and degradation of Shank proteins and to correlate with a requirement for protein degradation in memory extinction53.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [53] Lee, S. H. et al. Synaptic protein degradation underlies destabilization of retrieved fear memory. Science 319, 1253–1256 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationPtdIns(3,4,5)P3 binds and activates PDK1, which contributes to activation of Akt.
“This then binds and activates phosphoinositide-dependent protein kinase (PDK1), which in turn contributes to activation of the serine/threonine protein kinase Akt proteins.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Han, J. M. & Sahin, M. TSC1/TSC2 signaling in the CNS. FEBS Lett. 585, 973–980 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationLoss-of-function mutations in TSC1 or TSC2 in TSC result in deregulated mTOR signalling and abnormal neuronal protein synthesis.
“Loss of function mutations in TSC1 or TSC2 that occur in tuberous sclerosis complex, result in deregulated mTOR signalling and abnormal neuronal protein synthesis”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [13] Kelleher, R. J. III & Bear, M. F. The autistic neuron: troubled translation? Cell 135, 401–406 (2008). source
Not checked in the free run.
- cites [69] Ehninger, D. et al. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nature Med. 14, 843–848 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationActivation of MEF2 decreases the number of excitatory synapses in wild-type neurons but not in Fmr1 knockout neurons.
“activation of MEF2 leads to a decrease in the number of excitatory synapses in wild-type neurons, but not in Fmr1 knockout neurons”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [64] Pfeiffer, B. E. et al. Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2. Neuron 66, 191–197 (2010). source
Not checked in the free run.
May combine two claims.
PremisecitationIn fear conditioning, Tsc2+/- mice have a defect in distinguishing familiar and new contexts, which can be corrected by augmentation of mGluR5 signalling.
“In a fear conditioning behavioural model, Tsc2+/− mice have a defect in distinguishing familiar and new contexts, a defect that can also be corrected by augmentation of mGluR5 signalling71.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [71] Auerbach, B. D., Osterweil, E. K. & Bear, M. F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480, 63–68 (2011). This paper shows that loss of function of either TSC1–TSC2 or FMRP disrupts activity-regulated mRNA translation and synaptic plasticity in opposite directions. source
Not checked in the free run.
May combine two claims.
InterpretationreasoningIn the absence of FMRP, Arc protein level is abnormally high, so further activation of Arc transcription by MEF2 may not have much effect on synapse number.
“However, in the absence of FMRP, the level of Arc protein is abnormally high, so that further activation of Arc transcription by MEF2 may not have much of an effect on synapse number.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningInactivating PTEN mutations lead to excessive PI(3)K-AKT and mTOR signalling, which may lead to abnormal protein synthesis and ultimately synaptic dysfunction and ASD.
“Mutations that inactivate PTEN lead to excessive PI(3)K–AKT and mTOR signalling and in this way may lead to abnormal protein synthesis, and ultimately synaptic dysfunction and ASD.”
Quote in the paperSubstantial claim- Rests on an assumption: Mutations in PTEN, a negative regulator of PI(3)K-AKT signalling upstream of TSC1-TSC2, result in syndromic ASD.
May combine two claims.
PremisecitationNewly synthesized BDNF is secreted from excitatory neurons and acts near its release site to regulate synaptic development and plasticity, including development of inhibitory synapses.
“Newly synthesized BDNF is then secreted from excitatory neurons and functions near the site of release to regulate synaptic development and plasticity, including the development of inhibitory synapses30.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [30] Hong, E. J., McCord, A. E. & Greenberg, M. E. A biological function for the neuronal activity-dependent component of Bdnf transcription in the development of cortical inhibition. Neuron 60, 610–624 (2008). source
Not checked in the free run.
May combine two claims.
InterpretationcitationExcessive mTOR activity leads to decreased protein synthesis and LTD deficiency in Tsc2+/- mice.
“suggesting that excessive mTOR activity leads to decreased protein synthesis and LTD deficiency in Tsc2+/− mice71.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [71] Auerbach, B. D., Osterweil, E. K. & Bear, M. F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480, 63–68 (2011). This paper shows that loss of function of either TSC1–TSC2 or FMRP disrupts activity-regulated mRNA translation and synaptic plasticity in opposite directions. source
Not checked in the free run.
May combine two claims.
PremisecitationMany other FMRP targets are involved in synaptic plasticity, and there is significant overlap between FMRP targets and ASD candidate genes including NLGN3, NRXN1, SHANK3, PTEN, TSC1, and NF1.
“Many other FMRP targets have been shown to be involved in synaptic plasticity, and there is significant overlap between FMRP targets and ASD candidate genes, including NLGN3, NRXN1, SHANK3, PTEN, TSC1 and NF123,33.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [23] Bhakar, A. L., Dolen, G. & Bear, M. F. The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci. 35, 417–443 (2012). source
Not checked in the free run.
- cites [33] Darnell, J. C. et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247–261 (2011). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningFMRP is a key regulator of activity-dependent mRNA translation and synaptic plasticity, and dysregulation of this pathway may contribute significantly to ASD phenotypes.
“Taken together, these studies implicate FMRP as a key regulator of activity-dependent mRNA translation and synaptic plasticity and suggest that dysregulation of this pathway may contribute significantly to ASD phenotypes.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationBDNF binding to TrkB activates PI(3)K, which phosphorylates PtdIns(4,5)P2 to generate PtdIns(3,4,5)P3.
“BDNF binding to TrkB activates the phosphatidylinositol-3-OH kinase (PI(3)K), which phosphorylates phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) at the 3′ position to generate phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Han, J. M. & Sahin, M. TSC1/TSC2 signaling in the CNS. FEBS Lett. 585, 973–980 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationTsc2+/- mice have deficient mGluR-LTD in the hippocampus but no defect in basal synaptic transmission.
“Mice with a heterozygous loss of function mutation in Tsc2 (Tsc2+/−) have deficient mGluR–LTD in the hippocampus, but no defect in basal synaptic transmission.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [71] Auerbach, B. D., Osterweil, E. K. & Bear, M. F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480, 63–68 (2011). This paper shows that loss of function of either TSC1–TSC2 or FMRP disrupts activity-regulated mRNA translation and synaptic plasticity in opposite directions. source
Not checked in the free run.
May combine two claims.
InterpretationcitationFindings of deficient mGluR-LTD in Tsc1/Tsc2 deletion mice contrast with Fmr1 knockout mice, which have increased mGluR-LTD and excessive protein synthesis.
“These findings of deficient mGluR–LTD in mice with deletions in Tsc1 or Tsc2 are in contrast with Fmr1 knockout mice, which have increased mGluR–LTD and excessive protein synthesis57.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [57] Osterweil, E. K., Krueger, D. D., Reinhold, K. & Bear, M. F. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. J. Neurosci. 30, 15616–15627 (2010). source
Not checked in the free run.
May combine two claims.
PremisecitationInhibition of mTOR in Tsc2+/- mice restored mGluR-LTD and normalized protein synthesis rates to wild-type levels.
“Inhibition of mTOR in Tsc2+/− mice restored mGluR–LTD and normalized protein synthesis rates to that of wild-type mice rates”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [71] Auerbach, B. D., Osterweil, E. K. & Bear, M. F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480, 63–68 (2011). This paper shows that loss of function of either TSC1–TSC2 or FMRP disrupts activity-regulated mRNA translation and synaptic plasticity in opposite directions. source
Not checked in the free run.
May combine two claims.
PremisecitationTSC is caused by mutations in TSC1 or TSC2, which encode tumour suppressor proteins forming the TSC1-TSC2 complex that regulates protein synthesis in many mammalian cell types including neurons.
“This disorder is caused by mutations in TSC1 or TSC2 that encode tumour suppressor proteins which form the complex TSC1–TSC2 that regulate protein synthesis in a wide range of mammalian cell types, including neurons67.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Han, J. M. & Sahin, M. TSC1/TSC2 signaling in the CNS. FEBS Lett. 585, 973–980 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationPhosphorylation of TSC2 leads to Rheb activation, which triggers mTOR activation, contributing to protein synthesis.
“Thus, phosphorylation of TSC2 leads to Rheb activation, which in turn triggers activation of the protein kinase mTOR, contributing to the activation of protein synthesis (Fig. 4)67.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Han, J. M. & Sahin, M. TSC1/TSC2 signaling in the CNS. FEBS Lett. 585, 973–980 (2011). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningProper synaptic function in response to neuronal activity requires tight regulation of protein synthesis at synapses; TSC1/TSC2 and Fmr1 mutations disrupt this balance in opposite directions, leading to synaptic plasticity defects that may contribute to ASD phenotypes.
“These findings suggest that, for proper synaptic function in response to neuronal activity, protein synthesis at synapses is tightly regulated, and TSC1 and TSC2 as well as Fmr1 mutations disrupt this balance in opposite directions, leading to defects in synaptic plasticity that may contribute to ASD phenotypes.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationInhibition of mGluR5 in Fmr1 knockout mice corrects excessive protein synthesis and mGluR5-dependent LTD; augmentation of mGluR5 signalling restores protein synthesis and mGluR-dependent LTD in Tsc2+/- mice.
“Whereas inhibition of mGluR5 in Fmr1 knockout mice corrects excessive protein synthesis and mGluR5-dependent LTD, augmentation of mGluR5 signalling by a positive allosteric modulator restored protein synthesis and mGluR-dependent LTD in Tsc2+/− mice71.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [71] Auerbach, B. D., Osterweil, E. K. & Bear, M. F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480, 63–68 (2011). This paper shows that loss of function of either TSC1–TSC2 or FMRP disrupts activity-regulated mRNA translation and synaptic plasticity in opposite directions. source
Not checked in the free run.
May combine two claims.
InterpretationreasoningMECP2 is a key regulator of chromatin architecture and gene expression that modulates synaptic development, function, and plasticity.
“Together with the molecular studies of MECP2 function, these electrophysiological experiments suggest that MECP2 is a key regulator of chromatin architecture and gene expression that modulates synaptic development, function and plasticity.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn mice, this missense mutation leads to increased Ca2+ currents and loss of voltage-dependent channel inactivation.
“Studies in mice indicate that this missense mutation leads to increased Ca2+ currents and loss of voltage-dependent channel inactivation31,77.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [31] Splawski, I. et al. CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19–31 (2004). source
Not checked in the free run.
- cites [77] Barrett, C. F. & Tsien, R. W. The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels. Proc. Natl Acad. Sci. USA 105, 2157–2162 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationMice expressing a truncated Mecp2 variant lacking the C-terminal region have multiple defects in learning and memory and synaptic plasticity.
“mice expressing a truncated Mecp2 variant, lacking the C-terminal region, have multiple defects in learning and memory, as well as synaptic plasticity88.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [88] Moretti, P. et al. Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J. Neurosci. 26, 319–327 (2006). source
Not checked in the free run.
May combine two claims.
PremisecitationSer421Ala knock-in mice and wild-type mice express equivalent levels of MECP2, but Ser421Ala mice display increased dendritic complexity and increased inhibitory synaptic strength in the cortex.
“The Ser421Ala knock-in mice and wild-type mice express equivalent levels of MECP2, but the Ser421Ala knock-in mice display increased dendritic complexity and increased inhibitory synaptic strength in the cortex80.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [80] Cohen, S. et al. Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72, 72–85 (2011). This paper demonstrates the importance of activity-dependent regulation of MECP2 in the control of synapse development and behaviour. source
Not checked in the free run.
May combine two claims.
InterpretationreasoningUBE3A expression in the nervous system is kept in check through imprinting and is further regulated by neuronal activity.
“Thus, the level of the gene's expression in the nervous system is kept in check through imprinting and is further regulated by neuronal activity.”
Quote in the paperSubstantial claim- Rests on an assumption: The paternally inherited allele of UBE3A is imprinted and specifically silenced in the brain.
May combine two claims.
InterpretationreasoningDysregulation of at least some MECP2 functions likely leads to Rett syndrome and possibly other ASD.
“It is likely that the dysregulation of at least some of MECP2 functions lead to Rett syndrome and possibly other ASD.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationCompared to wild-type neurons, Timothy syndrome neurons had impaired Ca2+ channel inactivation and a significant increase in sustained intracellular Ca2+ elevation after membrane depolarization.
“Compared with wild-type neurons, the Timothy syndrome neurons had impaired Ca2+ channel inactivation and a significant increase in sustained intracellular Ca2+ elevation after membrane depolarization.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] Pasca, S. P. et al. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nature Med. 17, 1657–1662 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationLoss of MECP2 changes the balance between inhibition and excitation in the brain, altering the neuronal response to sensory experience.
“There is also evidence that loss of MECP2 changes the balance between inhibition and excitation in the brain, altering the neuronal response to sensory experience.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [86] Dani, V. S. et al. Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc. Natl Acad. Sci. USA 102, 12560–12565 (2005). source
Not checked in the free run.
- cites [87] Chao, H. T., Zoghbi, H. Y. & Rosenmund, C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56, 58–65 (2007). source
Not checked in the free run.
- cites [88] Moretti, P. et al. Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J. Neurosci. 26, 319–327 (2006). source
Not checked in the free run.
May combine two claims.
PremisecitationDuring late development when visual experience is required, synapses in the retinogeniculate circuit are abnormal in Mecp2 knockout mice, resulting in impaired synaptic plasticity on visual deprivation.
“during a late stage of development when visual experience is required for modulation and maintenance of the retinogeniculate circuit, the synapses that form on the neurons within this circuit are abnormal in Mecp2 knockout mice, resulting in impaired synaptic plasticity on visual deprivation85.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] Noutel, J., Hong, Y. K., Leu, B., Kang, E. & Chen, C. Experience-dependent retinogeniculate synapse remodeling is abnormal in MeCP2-deficient mice. Neuron 70, 35–42 (2011). source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
InterpretationcitationLoss of experience-dependent induction of UBE3A mRNA during postnatal development may contribute to Angelman syndrome, and increased activity-dependent UBE3A expression may underlie some forms of ASD.
“it has therefore been suggested that a loss of experience-dependent induction of the UBE3A mRNA during post-natal development may contribute to Angelman syndrome, and increased activity-dependent UBE3A expression may underlie some forms of ASD89.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Greer, P. L. et al. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating Arc. Cell 140, 704–716 (2010). This study provides insight into the molecular mechanisms underlying Angelman syndrome and the role of neuronal activity in regulating UBE3A and its targets. source
Not checked in the free run.
May combine two claims.
InterpretationreasoningUbe3a protein regulates excitatory-inhibitory balance during brain development, and when its expression is perturbed ASD may occur.
“These studies suggest that Ube3a protein regulates excitatory–inhibitory balance during brain development and that when the level of expression is perturbed ASD may occur.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [90] Jiang, Y. H. et al. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21, 799–811 (1998). source
Not checked in the free run.
- cites [91] Yashiro, K. et al. Ube3a is required for experience-dependent maturation of the neocortex. Nature Neurosci. 12, 777–783 (2009). source
Not checked in the free run.
- cites [92] Wallace, M. L., Burette, A. C., Weinberg, R. J. & Philpot, B. D. Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects. Neuron 74, 793–800 (2012). source
Not checked in the free run.
May combine two claims.
PremisecitationIn Mecp2 knockout mice, whole-cell patch clamp recordings in the somatosensory cortex revealed decreased excitatory synaptic drive and increased inhibitory drive onto L5 pyramidal cells.
“In Mecp2 knockout mice, whole-cell patch clamp recordings in the somatosensory cortex revealed decreased excitatory synaptic drive and increased inhibitory drive onto L5 pyramidal cells86.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [86] Dani, V. S. et al. Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc. Natl Acad. Sci. USA 102, 12560–12565 (2005). source
Not checked in the free run.
May combine two claims.
InterpretationcitationActivity-dependent phosphorylation of MECP2 regulates synapse development and function and behavioural responses to environmental stimuli.
“These findings indicate that activity-dependent phosphorylation of MECP2 regulates synapse development and function and behavioural responses to environmental stimuli.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [80] Cohen, S. et al. Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72, 72–85 (2011). This paper demonstrates the importance of activity-dependent regulation of MECP2 in the control of synapse development and behaviour. source
Not checked in the free run.
May combine two claims.
PremisecitationMice with a deletion in the maternal copy of Ube3A have impairments in learning and in the LTP form of synaptic plasticity.
“Mice that carry a deletion in the maternal copy of Ube3A have impairments in learning and in the LTP form of synaptic plasticity90.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [90] Jiang, Y. H. et al. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21, 799–811 (1998). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationReferences 47-49 report mouse models of Shank mutations that demonstrate Shanks' role in regulating excitatory neurotransmission.
“References 47–49 report the studies of mouse models of Shank mutations to demonstrate the role of Shanks in regulating excitatory neurotransmission.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [47] Peca, J. et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472, 437–442 (2011). source
Not checked in the free run.
- cites [48] Schmeisser, M. J. et al. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 486, 256–260 (2012). source
Not checked in the free run.
- cites [49] Won, H. et al. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486, 261–265 (2012). References 47–49 demonstrate the role of Shanks in regulating excitatory neurotransmission. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationReference 34 provides evidence that genetic mutations linked to autism may disrupt activity-dependent gene expression programs.
“This paper provides evidence for the hypothesis that genetic mutations associated with autism may disrupt activity-dependent gene expression programs.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Morrow, E. M. et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 321, 218–223 (2008). This paper provides evidence for the hypothesis that genetic mutations associated with ASD may disrupt activity-dependent gene expression programs. source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationReference 41 reports that neuroligins have a crucial role in activity-dependent synapse maturation and that this pathway is dysregulated by ASD-associated neuroligin mutations.
“This study reports the crucial role for neuroligins in activity-dependent synapse maturation and how this pathway is dysregulated by ASD-associated mutations in neuroligin.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [41] Chubykin, A. A. et al. Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 54, 919–931 (2007). This study reports the crucial role for neuroligins in activity-dependent synapse maturation and how this pathway is dysregulated by ASD-associated mutations in neuroligin. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationReferences 7-10 used exome and whole-genome sequencing to show the importance of rare mutations in ASD and to identify new genetic mutations linked to ASD.
“References 7– 10 use exome and entire genome sequencing to demonstrate the importance of rare mutations in ASD and identify new genetic mutations associated with ASD.”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [7] Sanders, S. J. et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237–241 (2012). source
Not checked in the free run.
- cites [8] Neale, B. M. et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242–245 (2012). source
Not checked in the free run.
- cites [9] O'Roak, B. J. et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nature Genet. 43, 585–589 (2011). source
Not checked in the free run.
- cites [10] Kong, A. et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 488, 471–475 (2012). References 7–10 demonstrate the ability of new sequencing technologies to significantly advance our understanding of the genetic basis of ASD. source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningASD-associated mutations in the Ras-MAPK pathway may disrupt activity-dependent synaptic development and plasticity by changing activity-regulated mRNA translation or gene transcription.
“mutations in this pathway that are associated with ASD may be disrupting activity-dependent synaptic development and plasticity by altering activity-regulated mRNA translation or gene transcription.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationReference 43 shows in Aplysia that the neurexin-neuroligin interaction controls activity-dependent synaptic development and plasticity, and that an ASD-associated neuroligin mutation disrupts this process.
“Using the Aplysia model system, this study demonstrates that the neurexin-neuroligin interaction regulates activity-dependent synaptic development and plasticity, a process that is dysregulated by an ASD-associated mutation in neuroligin.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [43] Choi, Y. B. et al. Neurexin-neuroligin transsynaptic interaction mediates learning-related synaptic remodeling and long-term facilitation in Aplysia. Neuron 70, 468–481 (2011). Using the Aplysia model, this study demonstrates that the neurexin–neuroligin interaction regulates activity-dependent synaptic development and plasticity, a process that is dysregulated by an ASD-associated mutation in neuroligin. source
Not checked in the free run.
May combine two claims.
PremisecitationThe Ras-MAPK pathway is required for protein synthesis regulated by activity, transcription of genes dependent on activity, and synaptic plasticity mediated by mGluR.
“As the Ras–MAPK signalling pathway is crucial for activity-regulated protein synthesis, activity-dependent gene transcription and mGluR dependent synaptic plasticity23,25,95”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [23] Bhakar, A. L., Dolen, G. & Bear, M. F. The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci. 35, 417–443 (2012). source
Not checked in the free run.
- cites [25] Dolmetsch, R. E., Pajvani, U., Fife, K., Spotts, J. M. & Greenberg, M. E. Signaling to the nucleus by an L-type calcium channel–calmodulin complex through the MAP kinase pathway. Science 294, 333–339 (2001). source
Not checked in the free run.
- cites [95] Kelleher, R. J. III, Govindarajan, A., Jung, H. Y., Kang, H. & Tonegawa, S. Translational control by MAPK signaling in long-term synaptic plasticity and memory. Cell 116, 467–479 (2004). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThose studies show that new sequencing technologies can greatly advance knowledge of the genetic basis of ASD.
“These studies demonstrate the ability of new sequencing technologies to significantly advance our understanding of the genetic basis of ASD.”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [7] Sanders, S. J. et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237–241 (2012). source
Not checked in the free run.
- cites [8] Neale, B. M. et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242–245 (2012). source
Not checked in the free run.
- cites [9] O'Roak, B. J. et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nature Genet. 43, 585–589 (2011). source
Not checked in the free run.
- cites [10] Kong, A. et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 488, 471–475 (2012). References 7–10 demonstrate the ability of new sequencing technologies to significantly advance our understanding of the genetic basis of ASD. source
Not checked in the free run.
May combine two claims.
InterpretationcitationDysregulation of Arc levels and AMPA receptor expression at synapses may contribute to ASD phenotypes in Angelman syndrome and possibly ASD involving CNVs on chromosome 15.
“Thus, the dysregulation of Arc levels and AMPA receptor expression at synapses may contribute to the ASD phenotypes observed in Angelman syndrome and possibly ASD that involve CNVs on chromosome 15.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Greer, P. L. et al. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating Arc. Cell 140, 704–716 (2010). This study provides insight into the molecular mechanisms underlying Angelman syndrome and the role of neuronal activity in regulating UBE3A and its targets. source
Not checked in the free run.
May combine two claims.
PremisecitationMutations in several components of the Ras-MAPK pathway have been associated with ASD, including rare mutations in HRAS, MAP2K2 and SYNGAP1, and with syndromes that have ASD features and mutations in NF1, MAP2K1, MAP2K2.
“Mutations in multiple components of this pathway have recently been found to be associated with ASD, including rare mutations in HRAS, MAP2K2 and SYNGAP1, and with syndromes with ASD features (that have mutations in NF1, MAP2K1, MAP2K2)93,94.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [93] Kelleher, R. J. III et al. High-throughput sequencing of mGluR signaling pathway genes reveals enrichment of rare variants in autism. PLoS ONE 7, e35003 (2012). source
Not checked in the free run.
- cites [94] Pinto, D. et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466, 368–372 (2010). source
Not checked in the free run.
May combine two claims.
PremisecitationIncreased Arc expression in the absence of UBE3A results in decreased AMPA receptor cell surface expression and decreased AMPA receptor-mediated currents.
“The increased level of Arc expression in the absence of UBE3A results in decreased AMPA receptor cell surface expression and a decrease in the AMPA receptor-mediated currents89.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Greer, P. L. et al. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating Arc. Cell 140, 704–716 (2010). This study provides insight into the molecular mechanisms underlying Angelman syndrome and the role of neuronal activity in regulating UBE3A and its targets. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationReference 89 gives insight into the molecular mechanisms of Angelman syndrome and the role of neuronal activity in regulating Ube3A and its targets.
“This study provides insight into the molecular mechanisms underlying Angelman syndrome and the role of neuronal activity in regulating Ube3A and its targets.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [89] Greer, P. L. et al. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating Arc. Cell 140, 704–716 (2010). This study provides insight into the molecular mechanisms underlying Angelman syndrome and the role of neuronal activity in regulating UBE3A and its targets. source
Not checked in the free run.
The paper relies on this without support.
Findings from animal models (rodents, Aplysia) about the synaptic and behavioural effects of ASD-associated mutations are informative about the molecular basis of human ASD.
“These studies indicate that particular ASD mutations in neurexins or neuroligins disrupt excitatory or inhibitory neurotransmission in the brain in specific ways and suggest that modelling ASD-associated mutations in mice will be important for elucidating how each mutation affects synaptic function and give rise to ASD.”
The paper relies on this without support.
The activity-dependent signalling pathways that regulate synapse development and plasticity in model organisms operate similarly in humans.
“A cardinal feature of human brain development is that sensory, cognitive and emotional experiences shape synapse and neural-circuit development.”
The paper relies on this without support.
Phelan-McDermid syndrome is an ASD resulting from a microdeletion that includes heterozygous loss of SHANK3.
“In particular, Phelan-McDermid syndrome is an ASD that results from a microdeletion that includes heterozygous loss of SHANK3.”
The paper relies on this without support.
Long-lasting synaptic plasticity elicited by glutamate binding to NMDA receptors or group 1 mGluRs typically requires protein synthesis mediated by mRNAs and ribosomes localized near synapses.
“Long-lasting forms of synaptic plasticity that are elicited by glutamate binding to NMDA receptors or group 1 mGluRs, typically require protein synthesis that is mediated by mRNAs and ribosomes that are localized near synapses.”
The paper relies on this without support.
Long-lasting NMDA receptor-dependent LTP and LTD have a delayed requirement for protein synthesis, whereas mGluR-dependent LTD requires protein synthesis that occurs within minutes.
“Long-lasting NMDA receptor-dependent LTP and LTD have a delayed requirement for protein synthesis, whereas mGluR-dependent LTD requires protein synthesis that occurs within minutes.”
The paper relies on this without support.
Fragile X syndrome is caused by mutations in FMR1, resulting in decreased expression of the RNA-binding protein FMRP.
“Fragile X syndrome is caused by mutations in FMR1, resulting in decreased expression of the RNA-binding protein FMRP.”
The paper relies on this without support.
Arc protein promotes internalization of AMPA receptors at excitatory synapses.
“The protein encoded by this activity-regulated gene promotes the internalization of AMPA receptors at excitatory synapses.”
The paper relies on this without support.
During early postnatal brain development, neuronal activity promotes changes in glutamate receptor subtype that are required for proper maturation of excitatory thalamocortical synapses in the somatosensory cortex.
“During early post-natal brain development, neuronal activity promotes changes in glutamate receptor subtype that are required for proper maturation of excitatory thalamocortical synapses in the somatosensory cortex.”
The paper relies on this without support.
TSC is characterized by benign tumours in multiple organs and a high penetrance of ASD.
“TSC is characterized by benign tumours in multiple organs as well as a high penetrance of ASD.”
The paper relies on this without support.
BDNF is a major activator of TSC1-TSC2 signalling in neurons; BDNF binds TrkB and mediates many aspects of brain development and function.
“One major activator of TSC1–TSC2 signalling in neurons is brain-derived neurotrophic factor (BDNF), a secreted protein that binds to the receptor tyrosine kinase TrkB on the surface of neurons and thereby mediates many aspects of brain development and function.”
The paper relies on this without support.
Neuronal activity potently induces Bdnf transcription in excitatory neurons.
“Neuronal activity potently induces Bdnf transcription in excitatory neurons.”
The paper relies on this without support.
Mutations in PTEN, a negative regulator of PI(3)K-AKT signalling upstream of TSC1-TSC2, result in syndromic ASD.
“mutations in PTEN, a negative regulator of PI(3)K–AKT signalling upstream of TSC1–TSC2, also result in syndromic ASD.”
The paper relies on this without support.
Neuronal activity regulates programs of gene expression in the nucleus that modulate synaptic development and plasticity.
“neuronal activity regulates programs of gene expression in the nucleus that modulate synaptic development and plasticity.”
The paper relies on this without support.
L-type calcium channels are voltage-gated and open upon membrane depolarization.
“The L-type calcium channels are voltage-gated and thus open upon membrane depolarization.”
The paper relies on this without support.
Mutations in MECP2 lead to Rett syndrome, an ASD characterized by impaired language development, loss of social engagement, stereotyped hand movements, seizures, and motor-system disabilities.
“Mutations in MECP2 lead to Rett syndrome, one form of ASD characterized by impaired language development, loss of social engagement, stereotyped hand movements, seizures and motor-system disabilities.”
The paper relies on this without support.
MECP2 binds methylated cytosines in DNA and seems to function mainly as a transcriptional repressor.
“MECP2 binds methylated cytosines within DNA and seems to function mainly as a transcriptional repressor.”
The paper relies on this without support.
MECP2 expression in post-mitotic neurons is about tenfold higher than in other cell types.
“The level of MECP2 expression in post-mitotic neurons is about tenfold higher than in other cell types”
The paper relies on this without support.
MECP2 expression in mature neurons is similar to that of core histones, and MECP2 is bound broadly across the genome.
“the level of MECP2 expression in mature neurons is similar to that of core histones, and MECP2 is bound broadly across the genome.”
The paper relies on this without support.
Angelman syndrome is characterized by motor dysfunction, speech impairment, seizures, and high prevalence of autism, and is caused by deletions of the maternally inherited allele of chromosomal region 15q11-q13.
“Angelman syndrome is characterized by motor dysfunction, speech impairment, seizures and high prevalence of autism, and is caused by deletions of the maternally inherited allele of chromosomal region 15q11–q13.”
The paper relies on this without support.
Loss of UBE3A function in this chromosomal region is by itself sufficient to cause Angelman syndrome.
“The loss of UBE3A function in this chromosomal region is by itself sufficient to cause Angelman syndrome.”
The paper relies on this without support.
CNVs that lead to duplications and triplications of the same chromosomal region are associated with ASD.
“CNVs that lead to duplications and triplications of the same chromosomal region are associated with ASD.”
The paper relies on this without support.
The paternally inherited allele of UBE3A is imprinted and specifically silenced in the brain.
“the paternally inherited allele of UBE3A is imprinted, and specifically silenced in the brain.”
The paper relies on this without support.
UBE3A is a member of a family of E3 ubiquitin ligases that catalyse ubiquitination of substrates, often leading to proteasomal degradation.
“UBE3A is a member of a family of E3 ubiquitin ligases, which catalyse the ubiquitination of substrates, often leading to the degradation of the ubiquitinated substrate by the proteasome.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Disruption in dendritic morphogenesis, synaptogenesis or activity-dependent remodelling produces network-wide deficits in neuronal connectivity.
“A disruption in any of these processes produces network-wide deficits in neuronal connectivity”
From The autism and schizophrenia associated gene CYFIP1 is critical for the maintenance of dendritic complexity and the stabilization of mature spines (2014) · cites this paper as [18]
The ‘Neuronal activity regulates synapses and circuits’ section says activity regulates synaptic development and plasticity, altering neural circuits. The Abstract also links disrupted activity-dependent synapse development to altered neurotransmission. But the paper does not establish that disruption of any one of the named processes necessarily produces network-wide connectivity deficits; its broader causal discussion remains qualified. (LLM, conf=0.85)
Experimental — accuracy not yet measuredChanges in morphological complexity, dendritic spine number, shape and plasticity are associated with several neuropsychiatric and neurological disorders, including schizophrenia, autism spectrum disorder, intellectual disability and epilepsy.
“changes in morphological complexity, dendritic spine number, shape and plasticity are associated with several neuropsychiatric and neurological disorders, including SCZ, ASD, ID and epilepsy.16, 17, 18, 19”
From The autism and schizophrenia associated gene CYFIP1 is critical for the maintenance of dendritic complexity and the stabilization of mature spines (2014) · cites this paper as [18]
The 'Synaptic proteins implicated in ASD > Shanks' section (page not supplied) links synaptic morphology and function to ASD-associated mutations, supporting the ASD portion. The paper also says that people with ASD often have intellectual disability and seizures, but it does not establish the claimed association of dendritic changes with schizophrenia, intellectual disability and epilepsy as separate disorders, or document all the specified changes in spine number, shape and plasticity. (LLM, conf=0.86)
Experimental — accuracy not yet measuredNeuronal depolarization communication proceeds through various signaling cascades and regulates intranuclear events such as enhancer recruitment, transcription factor activation, and alternative pre-mRNA splicing.
“Communication of neuronal depolarization proceeds by a variety of signaling cascades and regulates intranuclear events such as enhancer recruitment (Kim et al., 2010), transcription factor activation (Ebert and Greenberg, 2013) and alternative pre-mRNA splicing (Li et al., 2007).”
From Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops (2016) · cites this paper as Ebert and Greenberg, 2013
ASD-associated mutations that alter neurotransmission ultimately disrupt activity-dependent signaling to the nucleus.
“Likewise, ASD-associated mutations that alter neurotransmission ultimately disrupt activity-dependent signaling to the nucleus (Ebert and Greenberg, 2013).”
From Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops (2016) · cites this paper as Ebert and Greenberg, 2013
Several genes associated with ASD are regulated by neuronal activity.
“several genes associated with ASD are regulated by neuronal activity 20”
From Progress toward treatments for synaptic defects in autism (2013) · cites this paper as [20]
In some ASD cases, postmortem brain tissue, particularly prefrontal cortex, shows more activated microglia with a changed distribution.
“Activated microglia are present in increased numbers and with an altered distribution in postmortem brain tissue, especially the prefrontal cortex, in a subset of ASD cases115,137,209,210.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [209]
Variation in the assembly and dynamic maintenance of specific neural circuits, primarily in the cerebral cortex and subcortical structures such as the basal ganglia and the amygdala, are at the core of psychiatric disease.
“Increasing evidence suggests that variation in the assembly and dynamic maintenance of specific neural circuits, primarily in the cerebral cortex and subcortical structures such as the basal ganglia and the amygdala, are at the core of psychiatric disease 20-23 .”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [21]
Activity of receptor tyrosine kinases, metabotropic glutamic receptors and NMDA receptors leads to activation of PI3K/AKT and RAS/ERK signaling pathways, and thereby influences synaptic plasticity by mediating expression and trafficking of AMPA receptors in excitatory synapses and controlling LTD and LTP responses.
“Activity of receptor tyrosine kinases, metabotropic glutamic receptors and NMDA receptors lead to the activation of PI3K/AKT and RAS/ERK signaling pathways [185, 189], and thereby influence synaptic plasticity by mediating expression and trafficking of AMPA receptors in excitatory synapses and controlling long-term depression (LTD) and long-term potentiation (LTP) responses [188–190].”
From The ASD Living Biology: from cell proliferation to clinical phenotype (2019) · cites this paper as [189]
Evidence has accumulated that mutated ASD risk genes are critical components of activity-regulated signaling networks often controlling synapse development and morphology, as well as structural and functional plasticity.
“Evidence has accumulated that mutated ASD risk genes are critical components of activity-regulated signaling networks often controlling synapse development and morphology, as well as structural and functional plasticity [8].”
Cites
1 retracted
Thyagarajan, A., & Ting, A. Y. (2010) · Cell · doi:10.1016/j.cell.2010.09.025 · Cited by 35 · see citing works
RetractedMalenka, R. C., & Bear, M. F. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.012 · Cited by 3,968 · see citing works
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917 · see citing works
Widespread transcription at neuronal activity-regulated enhancers
Kim, T.-K., Hemberg, M., Gray, J. M., Costa, A. M., Bear, D. M., Wu, J., Harmin, D. A., Laptewicz, M., Barbara-Haley, K., Kuersten, S., et al. (2010) · Nature · doi:10.1038/nature09033 · Cited by 2,450 · see citing works
Self-citationRate of de novo mutations and the importance of father’s age to disease risk
Kong, A., Frigge, M. L., Masson, G., Besenbacher, S., Sulem, P., Magnusson, G., Gudjonsson, S. A., Sigurdsson, A., Jonasdottir, A., Jonasdottir, A., et al. (2012) · Nature · doi:10.1038/nature11396 · Cited by 2,134 · see citing works
Baird, G., Simonoff, E., Pickles, A., Chandler, S., Loucas, T., Meldrum, D., & Charman, T. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69041-7 · Cited by 2,104 · see citing works
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084 · see citing works
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072 · see citing works
Functional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013 · see citing works
Advances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866 · see citing works
Neuroligins and neurexins link synaptic function to cognitive disease
Südhof, T. C. (2008) · Nature · doi:10.1038/nature07456 · Cited by 1,849 · see citing works
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Neale, B. M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K. E., Sabo, A., Lin, C.-F., Stevens, C., Wang, L.-S., Makarov, V., et al. (2012) · Nature · doi:10.1038/nature11011 · Cited by 1,734 · see citing works
CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism
Splawski, I., Timothy, K. W., Sharpe, L. M., Decher, N., Kumar, P., Bloise, R., Napolitano, C., Schwartz, P. J., Joseph, R. M., Condouris, K., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.011 · Cited by 1,586 · see citing works
The mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · see citing works
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction
Peça, J., Feliciano, C., Ting, J. T., Wang, W., Wells, M. F., Venkatraman, T. N., Lascola, C. D., Fu, Z., & Feng, G. (2011) · Nature · doi:10.1038/nature09965 · Cited by 1,570 · see citing works
Altered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · see citing works
Sanders, S. J., Ercan-Sencicek, A. G., Hus, V., Luo, R., Murtha, M. T., Moreno-De-Luca, D., Chu, S. H., Moreau, M. P., Gupta, A. R., Thomson, S. A., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.002 · Cited by 1,263 · see citing works
Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2
Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R., & Greenberg, M. E. (2003) · Science · doi:10.1126/science.1086446 · Cited by 1,232 · see citing works
Self-citationReversal of Neurological Defects in a Mouse Model of Rett Syndrome
Guy, J., Gan, J., Selfridge, J., Cobb, S., & Bird, A. (2007) · Science · doi:10.1126/science.1138389 · Cited by 1,230 · see citing works
Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations
O'Roak, B. J., Deriziotis, P., Lee, C., Vives, L., Schwartz, J. J., Girirajan, S., Karakoc, E., MacKenzie, A. P., Ng, S. B., Baker, C., et al. (2011) · Nature Genetics · doi:10.1038/ng.835 · Cited by 1,203 · see citing works
Regulation of Gene Expression in Hippocampal Neurons by Distinct Calcium Signaling Pathways
Bading, H., Ginty, D. D., & Greenberg, M. E. (1993) · Science · doi:10.1126/science.8097060 · Cited by 1,157 · see citing works
Self-citationNMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD).
Luscher, C., & Malenka, R. C. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005710 · Cited by 1,110 · see citing works
Naisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R. J., Worley, P. F., & Sheng, M. (1999) · Neuron · doi:10.1016/s0896-6273(00)80809-0 · Cited by 1,009 · see citing works
A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice
Tabuchi, K., Blundell, J., Etherton, M. R., Hammer, R. E., Liu, X., Powell, C. M., & Südhof, T. C. (2007) · Science · doi:10.1126/science.1146221 · Cited by 997 · see citing works
A Requirement for Local Protein Synthesis in Neurotrophin-Induced Hippocampal Synaptic Plasticity
Kang, H., & Schuman, E. M. (1996) · Science · doi:10.1126/science.273.5280.1402 · Cited by 985 · see citing works
Correction of Fragile X Syndrome in Mice
Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979 · see citing works
Postnatal development of the visual cortex and the influence of environment
Wiesel, T. N. (1982) · Nature · doi:10.1038/299583a0 · Cited by 978 · see citing works
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
Ehlers, M. D. (2003) · Nature Neuroscience · doi:10.1038/nn1013 · Cited by 977 · see citing works
Dolmetsch, R. E., Pajvani, U., Fife, K., Spotts, J. M., & Greenberg, M. E. (2001) · Science · doi:10.1126/science.1063395 · Cited by 900 · see citing works
Self-citationReversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis
Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008) · Nature Medicine · doi:10.1038/nm1788 · Cited by 879 · see citing works
Zhou, Z., Hong, E. J., Cohen, S., Zhao, W.-N., Ho, H.-Y. H., Schmidt, L., Chen, W. G., Lin, Y., Savner, E., Griffith, E. C., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.037 · Cited by 877 · see citing works
Self-citationCNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics
Malhotra, D., & Sebat, J. (2012) · Cell · doi:10.1016/j.cell.2012.02.039 · Cited by 854 · see citing works
Jiang, Y.-H., Armstrong, D., Albrecht, U., Atkins, C. M., Noebels, J. L., Eichele, G., Sweatt, J. D., & Beaudet, A. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80596-6 · Cited by 852 · see citing works
Translational Control by MAPK Signaling in Long-Term Synaptic Plasticity and Memory
Kelleher, R. J., Govindarajan, A., Jung, H.-Y., Kang, H., & Tonegawa, S. (2004) · Cell · doi:10.1016/s0092-8674(04)00115-1 · Cited by 845 · see citing works
Flavell, S. W., & Greenberg, M. E. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.060407.125631 · Cited by 832 · see citing works
Self-citationZoghbi, H. Y., & Bear, M. F. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009886 · Cited by 797 · see citing works
Stimulation of Neuronal Acetylcholine Receptors Induces Rapid Gene Transcription
Greenberg, M. E., Ziff, E. B., & Greene, L. A. (1986) · Science · doi:10.1126/science.3749894 · Cited by 761 · see citing works
Self-citationIdentifying autism loci and genes by tracing recent shared ancestry
Morrow, E. M., Yoo, S.-Y., Flavell, S. W., Kim, T.-K., Lin, Y., Hill, R. S., Mukaddes, N. M., Balkhy, S., Gascon, G., Hashmi, A., et al. (2008) · Science · doi:10.1126/science.1157657 · Cited by 737 · see citing works
Self-citationRegulation of Dendritic Spine Morphology and Synaptic Function by Shank and Homer
Sala, C., Piëch, V., Wilson, N. R., Passafaro, M., Liu, G., & Sheng, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00339-7 · Cited by 716 · see citing works
Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function
Won, H., Lee, H.-R., Gee, H. Y., Mah, W., Kim, J.-I., Lee, J., Ha, S., Chung, C., Jung, E. S., Cho, Y. S., et al. (2012) · Nature · doi:10.1038/nature11208 · Cited by 695 · see citing works
Neuronal MeCP2 Is Expressed at Near Histone-Octamer Levels and Globally Alters the Chromatin State
Skene, P. J., Illingworth, R. S., Webb, S., Kerr, A. R. W., James, K. D., Turner, D. J., Andrews, R., & Bird, A. P. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.030 · Cited by 688 · see citing works
Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., & Bagni, C. (2003) · Cell · doi:10.1016/s0092-8674(03)00079-5 · Cited by 676 · see citing works
Greer, P. L., & Greenberg, M. E. (2008) · Neuron · doi:10.1016/j.neuron.2008.09.002 · Cited by 661 · see citing works
Self-citationActivity-dependent regulation of inhibitory synapse development by Npas4
Lin, Y., Bloodgood, B. L., Hauser, J. L., Lapan, A. D., Koon, A. C., Kim, T.-K., Hu, L. S., Malik, A. N., & Greenberg, M. E. (2008) · Nature · doi:10.1038/nature07319 · Cited by 639 · see citing works
Self-citationDani, V. S., Chang, Q., Maffei, A., Turrigiano, G. G., Jaenisch, R., & Nelson, S. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506071102 · Cited by 639 · see citing works
Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2
Schmeisser, M. J., Ey, E., Wegener, S., Bockmann, J., Stempel, A. V., Kuebler, A., Janssen, A.-L., Udvardi, P. T., Shiban, E., Spilker, C., et al. (2012) · Nature · doi:10.1038/nature11015 · Cited by 638 · see citing works
The Postsynaptic Organization of Synapses
Sheng, M., & Kim, E. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005678 · Cited by 603 · see citing works
The Autistic Neuron: Troubled Translation?
Kelleher, R. J., & Bear, M. F. (2008) · Cell · doi:10.1016/j.cell.2008.10.017 · Cited by 598 · see citing works
Chubykin, A. A., Atasoy, D., Etherton, M. R., Brose, N., Kavalali, E. T., Gibson, J. R., & Südhof, T. C. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.029 · Cited by 594 · see citing works
Mutations causing syndromic autism define an axis of synaptic pathophysiology
Auerbach, B. D., Osterweil, E. K., & Bear, M. F. (2011) · Nature · doi:10.1038/nature10658 · Cited by 592 · see citing works
Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome
Paşca, S. P., Portmann, T., Voineagu, I., Yazawa, M., Shcheglovitov, A., Paşca, A. M., Cord, B., Palmer, T. D., Chikahisa, S., Nishino, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2576 · Cited by 585 · see citing works
Activity-Dependent Regulation of MEF2 Transcription Factors Suppresses Excitatory Synapse Number
Flavell, S. W., Cowan, C. W., Kim, T.-K., Greer, P. L., Lin, Y., Paradis, S., Griffith, E. C., Hu, L. S., Chen, C., & Greenberg, M. E. (2006) · Science · doi:10.1126/science.1122511 · Cited by 573 · see citing works
Self-citationLearning and Memory and Synaptic Plasticity Are Impaired in a Mouse Model of Rett Syndrome
Moretti, P., Levenson, J. M., Battaglia, F., Atkinson, R., Teague, R., Antalffy, B., Armstrong, D., Arancio, O., Sweatt, J. D., & Zoghbi, H. Y. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2623-05.2006 · Cited by 545 · see citing works
Park, S., Park, J. M., Kim, S., Kim, J.-A., Shepherd, J. D., Smith-Hicks, C. L., Chowdhury, S., Kaufmann, W., Kuhl, D., Ryazanov, A. G., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.05.023 · Cited by 516 · see citing works
MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse Number
Chao, H.-T., Zoghbi, H. Y., & Rosenmund, C. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.018 · Cited by 511 · see citing works
Waung, M. W., Pfeiffer, B. E., Nosyreva, E. D., Ronesi, J. A., & Huber, K. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.05.014 · Cited by 474 · see citing works
Hou, L., Antion, M. D., Hu, D., Spencer, C. M., Paylor, R., & Klann, E. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.005 · Cited by 469 · see citing works
Etherton, M. R., Blaiss, C. A., Powell, C. M., & Südhof, T. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910297106 · Cited by 447 · see citing works
Flavell, S. W., Kim, T.-K., Gray, J. M., Harmin, D. A., Hemberg, M., Hong, E. J., Markenscoff-Papadimitriou, E., Bear, D. M., & Greenberg, M. E. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.029 · Cited by 440 · see citing works
Self-citationSynaptic Protein Degradation Underlies Destabilization of Retrieved Fear Memory
Lee, S.-H., Choi, J.-H., Lee, N., Lee, H.-R., Kim, J.-I., Yu, N.-K., Choi, S.-L., Lee, S.-H., Kim, H., & Kaang, B.-K. (2008) · Science · doi:10.1126/science.1150541 · Cited by 409 · see citing works
Communication Between the Synapse and the Nucleus in Neuronal Development, Plasticity, and Disease
Cohen, S., & Greenberg, M. E. (2008) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.24.110707.175235 · Cited by 400 · see citing works
Self-citationOsterweil, E. K., Krueger, D. D., Reinhold, K., & Bear, M. F. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3888-10.2010 · Cited by 384 · see citing works
The Pathophysiology of Fragile X (and What It Teaches Us about Synapses)
Bhakar, A. L., Dölen, G., & Bear, M. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153138 · Cited by 370 · see citing works
Hong, E. J., McCord, A. E., & Greenberg, M. E. (2008) · Neuron · doi:10.1016/j.neuron.2008.09.024 · Cited by 366 · see citing works
Self-citationMuddashetty, R. S., Nalavadi, V. C., Gross, C., Yao, X., Xing, L., Laur, O., Warren, S. T., & Bassell, G. J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.006 · Cited by 364 · see citing works
Ube3a is required for experience-dependent maturation of the neocortex
Yashiro, K., Riday, T. T., Condon, K. H., Roberts, A. C., Bernardo, D. R., Prakash, R., Weinberg, R. J., Ehlers, M. D., & Philpot, B. D. (2009) · Nature Neuroscience · doi:10.1038/nn.2327 · Cited by 328 · see citing works
Phosphorylation influences the translation state of FMRP-associated polyribosomes
Ceman, S., O'Donnell, W. T., Reed, M., Patton, S., Pohl, J., & Warren, S. T. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg350 · Cited by 327 · see citing works
SHANK1 Deletions in Males with Autism Spectrum Disorder
Sato, D., Lionel, A. C., Leblond, C. S., Prasad, A., Pinto, D., Walker, S., O'Connor, I., Russell, C., Drmic, I. E., Hamdan, F. F., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.03.017 · Cited by 318 · see citing works
The conundrums of understanding genetic risks for autism spectrum disorders
State, M. W., & Levitt, P. (2011) · Nature Neuroscience · doi:10.1038/nn.2924 · Cited by 306 · see citing works
Barbosa, A. C., Kim, M.-S., Ertunc, M., Adachi, M., Nelson, E. D., McAnally, J., Richardson, J. A., Kavalali, E. T., Monteggia, L. M., Bassel-Duby, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802679105 · Cited by 303 · see citing works
Cohen, S., Gabel, H. W., Hemberg, M., Hutchinson, A. N., Sadacca, L. A., Ebert, D. H., Harmin, D. A., Greenberg, R. S., Verdine, V. K., Zhou, Z., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.022 · Cited by 298 · see citing works
Self-citationHardingham, G. E., Arnold, F. J. L., & Bading, H. (2001) · Nature Neuroscience · doi:10.1038/88380 · Cited by 290 · see citing works
Cocaine Regulates MEF2 to Control Synaptic and Behavioral Plasticity
Pulipparacharuvil, S., Renthal, W., Hale, C. F., Taniguchi, M., Xiao, G., Kumar, A., Russo, S. J., Sikder, D., Dewey, C. M., Davis, M. M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.020 · Cited by 281 · see citing works
van Woerden, G. M., Harris, K. D., Hojjati, M. R., Gustin, R. M., Qiu, S., de Avila Freire, R., Jiang, Y.-H., Elgersma, Y., & Weeber, E. J. (2007) · Nature Neuroscience · doi:10.1038/nn1845 · Cited by 281 · see citing works
SAM68 Regulates Neuronal Activity-Dependent Alternative Splicing of Neurexin-1
Iijima, T., Wu, K., Witte, H., Hanno-Iijima, Y., Glatter, T., Richard, S., & Scheiffele, P. (2011) · Cell · doi:10.1016/j.cell.2011.11.028 · Cited by 279 · see citing works
Deconstruction for Reconstruction: The Role of Proteolysis in Neural Plasticity and Disease
Bingol, B., & Sheng, M. (2011) · Neuron · doi:10.1016/j.neuron.2010.11.006 · Cited by 275 · see citing works
Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2
Giacometti, E., Luikenhuis, S., Beard, C., & Jaenisch, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610593104 · Cited by 271 · see citing works
CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease
Bhat, S., Dao, D. T., Terrillion, C. E., Arad, M., Smith, R. J., Soldatov, N. M., & Gould, T. D. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.001 · Cited by 271 · see citing works
Missler, M., Sudhof, T. C., & Biederer, T. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005694 · Cited by 255 · see citing works
Critical period plasticity is disrupted in the barrel cortex of FMR1 knockout mice
Harlow, E. G., Till, S. M., Russell, T. A., Wijetunge, L. S., Kind, P., & Contractor, A. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.024 · Cited by 252 · see citing works
Narayanan, U., Nalavadi, V., Nakamoto, M., Pallas, D. C., Ceman, S., Bassell, G. J., & Warren, S. T. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2969-07.2007 · Cited by 228 · see citing works
MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants
Deng, J. V., Rodriguiz, R. M., Hutchinson, A. N., Kim, I.-H., Wetsel, W. C., & West, A. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2614 · Cited by 206 · see citing works
Loss of Tsc1 In Vivo Impairs Hippocampal mGluR-LTD and Increases Excitatory Synaptic Function
Bateup, H. S., Takasaki, K. T., Saulnier, J. L., Denefrio, C. L., & Sabatini, B. L. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1617-11.2011 · Cited by 204 · see citing works
Wallace, M. L., Burette, A. C., Weinberg, R. J., & Philpot, B. D. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.036 · Cited by 196 · see citing works
PTEN signaling in autism spectrum disorders
Zhou, J., & Parada, L. F. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.05.004 · Cited by 188 · see citing works
Yu, T. W., Lim, E. T., Stevens, C. R., Gabriel, S., Chahrour, M. H., Ataman, B., Coulter, M. E., Hill, R. S., Schubert, C. R., Greenberg, M. E., et al. (2012) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 179 · see citing works
Self-citationBarrett, C. F., & Tsien, R. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710501105 · Cited by 174 · see citing works
Postnatal Development of the Visual Cortex and the Influence of Environment.
Wiesel, T. N. (1983) · American Journal of Ophthalmology · doi:10.1016/0002-9394(83)90365-3 · Cited by 163 · see citing works
Niere, F., Wilkerson, J. R., & Huber, K. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4650-11.2012 · Cited by 153 · see citing works
Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory
Li, H., Zhong, X., Chau, K. F., Williams, E. C., & Chang, Q. (2011) · Nature Neuroscience · doi:10.1038/nn.2866 · Cited by 153 · see citing works
Kim, J., Jung, S.-Y., Lee, Y. K., Park, S., Choi, J.-S., Lee, C. J., Kim, H.-S., Choi, Y.-B., Scheiffele, P., Bailey, C. H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803448105 · Cited by 153 · see citing works
Pfeiffer, B. E., Zang, T., Wilkerson, J. R., Taniguchi, M., Maksimova, M. A., Smith, L. N., Cowan, C. W., & Huber, K. M. (2010) · Neuron · doi:10.1016/j.neuron.2010.03.017 · Cited by 153 · see citing works
Etherton, M. R., Tabuchi, K., Sharma, M., Ko, J., & Südhof, T. C. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.182 · Cited by 140 · see citing works
Chahrour, M. H., Yu, T. W., Lim, E. T., Ataman, B., Coulter, M. E., Hill, R. S., Stevens, C. R., Schubert, C. R., ARRA Autism Sequencing Collaboration, Greenberg, M. E., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002635 · Cited by 125 · see citing works
Self-citationKelleher III, R. J., Geigenmüller, U., Hovhannisyan, H., Trautman, E., Pinard, R., Rathmell, B., Carpenter, R., & Margulies, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035003 · Cited by 116 · see citing works
Hung, A. Y., Sung, C. C., Brito, I. L., & Sheng, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009842 · Cited by 106 · see citing works
TSC1/TSC2 signaling in the CNS
Han, J. M., & Sahin, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.02.001 · Cited by 105 · see citing works
Experience-Dependent Retinogeniculate Synapse Remodeling Is Abnormal in MeCP2-Deficient Mice
Noutel, J., Hong, Y. K., Leu, B., Kang, E., & Chen, C. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.001 · Cited by 103 · see citing works
Choi, Y.-B., Li, H.-L., Kassabov, S. R., Jin, I., Puthanveettil, S. V., Karl, K. A., Lu, Y., Kim, J.-H., Bailey, C. H., & Kandel, E. R. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.020 · Cited by 94 · see citing works
The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating Arc
Greer, P. L., Hanayama, R., Bloodgood, B. L., Mardinly, A. R., Lipton, D. M., Flavell, S. W., Kim, T.-K., Griffith, E. C., Waldon, Z., Maehr, R., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.026 · Cited by 30 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism
Parikshak, N. N., Luo, R., Zhang, A., Won, H., Lowe, J. K., Chandran, V., Horvath, S., & Geschwind, D. H. (2013) · Cell · doi:10.1016/j.cell.2013.10.031 · Cited by 1,039 · see citing works
Sohal, V. S., & Rubenstein, J. L. R. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0426-0 · Cited by 988 · see citing works
From the genetic architecture to synaptic plasticity in autism spectrum disorder
Bourgeron, T. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3992 · Cited by 975 · see citing works
Precise minds in uncertain worlds: Predictive coding in autism.
Van de Cruys, S., Evers, K., Van der Hallen, R., Van Eylen, L., Boets, B., de-Wit, L., & Wagemans, J. (2014) · Psychological Review · doi:10.1037/a0037665 · Cited by 885 · see citing works
Integrative functional genomic analysis of human brain development and neuropsychiatric risks
Li, M., Santpere, G., Imamura Kawasawa, Y., Evgrafov, O. V., Gulden, F. O., Pochareddy, S., Sunkin, S. M., Li, Z., Shin, Y., Zhu, Y., et al. (2018) · Science · doi:10.1126/science.aat7615 · Cited by 810 · see citing works
Advancing the understanding of autism disease mechanisms through genetics
de la Torre-Ubieta, L., Won, H., Stein, J. L., & Geschwind, D. H. (2016) · Nature Medicine · doi:10.1038/nm.4071 · Cited by 827 · see citing works
Immune mediators in the brain and peripheral tissues in autism spectrum disorder
Estes, M. L., & McAllister, A. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3978 · Cited by 514 · see citing works
Maturation and circuit integration of transplanted human cortical organoids
Revah, O., Gore, F., Kelley, K. W., Andersen, J., Sakai, N., Chen, X., Li, M.-Y., Birey, F., Yang, X., Saw, N. L., et al. (2022) · Nature · doi:10.1038/s41586-022-05277-w · Cited by 504 · see citing works
Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders
Parikshak, N. N., Gandal, M. J., & Geschwind, D. H. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3934 · Cited by 430 · see citing works
Developmental timing and critical windows for the treatment of psychiatric disorders
Marín, O. (2016) · Nature Medicine · doi:10.1038/nm.4225 · Cited by 374 · see citing works
Adult restoration of Shank3 expression rescues selective autistic-like phenotypes
Mei, Y., Monteiro, P., Zhou, Y., Kim, J.-A., Gao, X., Fu, Z., & Feng, G. (2016) · Nature · doi:10.1038/nature16971 · Cited by 392 · see citing works
The ASD Living Biology: from cell proliferation to clinical phenotype
Courchesne, E., Pramparo, T., Gazestani, V. H., Lombardo, M. V., Pierce, K., & Lewis, N. E. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0056-y · Cited by 333 · see citing works
Mitochondria metabolism sets the species-specific tempo of neuronal development
Iwata, R., Casimir, P., Erkol, E., Boubakar, L., Planque, M., Gallego López, I. M., Ditkowska, M., Gaspariunaite, V., Beckers, S., Remans, D., et al. (2023) · Science · doi:10.1126/science.abn4705 · Cited by 312 · see citing works
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Querfurth, H., & Lee, H.-K. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00428-5 · Cited by 288 · see citing works
The Emerging Picture of Autism Spectrum Disorder: Genetics and Pathology
Chen, J. A., Peñagarikano, O., Belgard, T. G., Swarup, V., & Geschwind, D. H. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040405 · Cited by 254 · see citing works
Filice, F., Vörckel, K. J., Sungur, A. Ö., Wöhr, M., & Schwaller, B. (2016) · Molecular Brain · doi:10.1186/s13041-016-0192-8 · Cited by 240 · see citing works
Wöhr, M., Orduz, D., Gregory, P., Moreno, H., Khan, U., Vörckel, K. J., Wolfer, D. P., Welzl, H., Gall, D., Schiffmann, S. N., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.19 · Cited by 258 · see citing works
Progress toward treatments for synaptic defects in autism
Delorme, R., Ey, E., Toro, R., Leboyer, M., Gillberg, C., & Bourgeron, T. (2013) · Nature Medicine · doi:10.1038/nm.3193 · Cited by 218 · see citing works
Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR
Ebert, D. H., Gabel, H. W., Robinson, N. D., Kastan, N. R., Hu, L. S., Cohen, S., Navarro, A. J., Lyst, M. J., Ekiert, R., Bird, A. P., et al. (2013) · Nature · doi:10.1038/nature12348 · Cited by 227 · see citing works
Self-citationA Quantitative Framework to Evaluate Modeling of Cortical Development by Neural Stem Cells
Stein, J. L., de la Torre-Ubieta, L., Tian, Y., Parikshak, N. N., Hernández, I. A., Marchetto, M. C., Baker, D. K., Lu, D., Hinman, C. R., Lowe, J. K., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.035 · Cited by 201 · see citing works
Brain adaptation and alternative developmental trajectories
Johnson, M. H., Jones, E. J. H., & Gliga, T. (2015) · Development and Psychopathology · doi:10.1017/s0954579415000073 · Cited by 213 · see citing works
Linaro, D., Vermaercke, B., Iwata, R., Ramaswamy, A., Davis, B. A., Boubakar, L., Libé-Philippot, B., Bilheu, A., Bruyne, L. D., Gall, D., et al. (2019) · doi:10.1101/626218 · Cited by 210 · see citing works
“As this is a major readout of synaptic function within a whole circuit, this provides a unique opportunity to model human neuronal plasticity in health and disease (Cruz-Martı́n et al., 2010; Ebert and Greenberg, 2013; Murmu et al., 2013; Spires-Jones and Hyman, 2014; Zoghbi and Bear, 2012).”
BackgroundActivity-dependent neural plasticity from bench to bedside
Ganguly, K., & Poo, M.-M. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.028 · Cited by 202 · see citing works
Pathania, M., Davenport, E. C., Muir, J., Sheehan, D. F., López-Doménech, G., & Kittler, J. T. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.16 · Cited by 189 · see citing works
Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops
Mullins, C., Fishell, G., & Tsien, R. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.017 · Cited by 167 · see citing works
Quesnel-Vallières, M., Dargaei, Z., Irimia, M., Gonatopoulos-Pournatzis, T., Ip, J. Y., Wu, M., Sterne-Weiler, T., Nakagawa, S., Woodin, M. A., Blencowe, B. J., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.11.033 · Cited by 178 · see citing works
Developmental mechanisms underlying the evolution of human cortical circuits
Vanderhaeghen, P., & Polleux, F. (2023) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00675-z · Cited by 173 · see citing works
Keil, K. P., & Lein, P. J. (2016) · Environmental Epigenetics · doi:10.1093/eep/dvv012 · Cited by 167 · see citing works
Figlia, G., Gerber, D., & Suter, U. (2018) · Glia · doi:10.1002/glia.23273 · Cited by 165 · see citing works
A computational perspective on autism
Rosenberg, A., Patterson, J. S., & Angelaki, D. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510583112 · Cited by 156 · see citing works
Ernst, C. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.03.001 · Cited by 145 · see citing works
Zhubi, A., Chen, Y., Dong, E., Cook, E. H., Guidotti, A., & Grayson, D. R. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.123 · Cited by 154 · see citing works
Rescue of oxytocin response and social behaviour in a mouse model of autism
Hörnberg, H., Pérez-Garci, E., Schreiner, D., Hatstatt-Burklé, L., Magara, F., Baudouin, S., Matter, A., Nacro, K., Pecho-Vrieseling, E., & Scheiffele, P. (2020) · Nature · doi:10.1038/s41586-020-2563-7 · Cited by 154 · see citing works
Wen, Y., Alshikho, M. J., & Herbert, M. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153329 · Cited by 150 · see citing works
Kas, M. J., Glennon, J. C., Buitelaar, J., Ey, E., Biemans, B., Crawley, J., Ring, R. H., Lajonchere, C., Esclassan, F., Talpos, J., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3268-5 · Cited by 132 · see citing works
Santini, E., & Klann, E. (2014) · Science Signaling · doi:10.1126/scisignal.2005832 · Cited by 118 · see citing works
Polydoro, M., Dzhala, V. I., Pooler, A. M., Nicholls, S. B., McKinney, A. P., Sanchez, L., Pitstick, R., Carlson, G. A., Staley, K. J., Spires-Jones, T. L., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1215-5 · Cited by 117 · see citing works
Heise, C., Gardoni, F., Culotta, L., di Luca, M., Verpelli, C., & Sala, C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00035 · Cited by 99 · see citing works
Tian, Y., Voineagu, I., Paşca, S. P., Won, H., Chandran, V., Horvath, S., Dolmetsch, R. E., & Geschwind, D. H. (2014) · Genome Medicine · doi:10.1186/s13073-014-0075-5 · Cited by 93 · see citing works
Autism Spectrum Disorder Genetics: Diverse Genes with Diverse Clinical Outcomes
Talkowski, M. E., Minikel, E. V., & Gusella, J. F. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000002 · Cited by 72 · see citing works
Oxytocin: Parallel Processing in the Social Brain?
Dölen, G. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12284 · Cited by 65 · see citing works
Meeting report: can we make animal models of human mental illness?
Monteggia, L. M., Heimer, H., & Nestler, E. J. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.02.010 · Cited by 60 · see citing works
Current perspectives in autism spectrum disorder: from genes to therapy
Chahrour, M., O'Roak, B. J., Santini, E., Samaco, R. C., Kleiman, R. J., & Manzini, M. C. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2335-16.2016 · Cited by 54 · see citing works
A thalamo-preoptic pathway promotes social grooming in rodents
Keller, D., Láng, T., Cservenák, M., Puska, G., Barna, J., Csillag, V., Farkas, I., Zelena, D., Dóra, F., Küppers, S., et al. (2022) · Current Biology · doi:10.1016/j.cub.2022.08.062 · Cited by 54 · see citing works
Neuronal L-Type Calcium Channel Signaling to the Nucleus Requires a Novel CaMKIIα-Shank3 Interaction
Perfitt, T. L., Wang, X., Dickerson, M. T., Stephenson, J. R., Nakagawa, T., Jacobson, D. A., & Colbran, R. J. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0893-19.2020 · Cited by 54 · see citing works
Aller, M. I., Pecoraro, V., Paternain, A. V., Canals, S., & Lerma, J. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2217-15.2015 · Cited by 50 · see citing works
Intergenerational Metabolic Syndrome and Neuronal Network Hyperexcitability in Autism
Rivell, A., & Mattson, M. P. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.08.006 · Cited by 50 · see citing works
MET Receptor Tyrosine Kinase as an Autism Genetic Risk Factor
Peng, Y., Huentelman, M., Smith, C., & Qiu, S. (2013) · International Review of Neurobiology · doi:10.1016/b978-0-12-418700-9.00005-8 · Cited by 49 · see citing works
Zhang, Z., Cao, M., Chang, C.-W., Wang, C., Shi, X., Zhan, X., Birnbaum, S. G., Bezprozvanny, I., Huber, K. M., & Wu, J. I. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00534-15 · Cited by 48 · see citing works
Synaptic plasticity and cognitive function are disrupted in the absence of Lrp4
Gomez, A. M., Froemke, R. C., & Burden, S. J. (2014) · eLife · doi:10.7554/elife.04287 · Cited by 47 · see citing works
Mychasiuk, R., & Rho, J. M. (2017) · Autism Research · doi:10.1002/aur.1682 · Cited by 45 · see citing works
Developing new pharmacotherapies for autism
Ecker, C., Spooren, W., & Murphy, D. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12113 · Cited by 31 · see citing works
SYNGAP1 deficiency disrupts synaptic neoteny in xenotransplanted human cortical neurons in vivo
Vermaercke, B., Iwata, R., Wierda, K., Boubakar, L., Rodriguez, P., Ditkowska, M., Bonin, V., & Vanderhaeghen, P. (2024) · Neuron · doi:10.1016/j.neuron.2024.07.007 · Cited by 27 · see citing works
Song, N., Du, J., Gao, Y., & Yang, S. (2020) · Translational Neuroscience · doi:10.1515/tnsci-2020-0146 · Cited by 15 · see citing works
- Authors
- Ebert, D. H., & Greenberg, M. E.
- Affiliations
- Harvard University (US)
- Corresponding author
- Greenberg, Michael E.
- Venue
- Nature
- Published
- 2013-01-16
- Volume
- 493
- Issue
- 7432
- Pages
- 327-337
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3576027
- OpenAlex
- W2082023836
- Cited by
- 666
- References
- 100
- Citations by year
- 2026: 21 · 2025: 27 · 2024: 45 · 2023: 46 · 2022: 37 · 2021: 44 · 2020: 86 · 2019: 45 · 2018: 56 · 2017: 54 · 2016: 57 · 2015: 54 · 2014: 55 · 2013: 37 · 2012: 1
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (5r01ns048276-15)
- National Institute of Mental Health (K08MH090306, K08MH90306)
- National Institute of Neurological Disorders and Stroke (R01-NS-048276)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- autism spectrum disorder, synaptic plasticity, synaptic development, post-translational modification, dendritic protein synthesis, gene transcription, neural circuits, autism etiology
- MeSH terms
- Child, Child Development Disorders, Pervasive, Gene Expression Regulation, Humans, Neuronal Plasticity, Neurons, Synapses, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review